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ABSTRACT
The research work presented here is concerned with how 
a systematic study of the acid - base equilibria, polarographic 
and chromatographic behaviour of an antibiotic and its 
corresponding metal complexes can aid in the development of 
a sensitive analytical method to speciate these compounds 
The antibiotic studied here was one of the most used of 
all broad spectrum antibiotics namely oxytetracyclme 
hydrochloride.
A systematic study of the acid - base equilibria yielded 
four pK^ values pK^ = 3  3, pK^ = 7.5, pK^ = 9.7 and pK^ = 10.4. 
A systematic study in different buffers also using ultraviolet 
spectroscopy yielded information which was important in 
determining at which sites the metals studied were binding 
to the antibiotic. The Cu(II), Ni(II), Co(II) and Mg(II) ions 
binding in a similar fashion to the BCD chromophore of the 
antibiotic and the Fe(II) and Fe(III) ions binding in a 
different manner to the A chromophore of the antibiotic 
The polarographic study yielded information which was 
important in the identification of the process of reduction 
of oxytetracyclme hydrochloride. The first peak of reduction 
being due to the carbonyl group and its conjugated double bond 
in the A chromophore The remaining reduction peaks being 
due to the carbonyl groups and their conjugated double bonds 
in the BCD chromophore The polarographic information was 
also important in determining at which sites the metals studied
n
in
were binding to the antibiotic , the results obtained for this 
were in good agreement with the spectroscopic study
A systematic study of the chromatographic behaviour of 
oxytetracycline hydrochloride and its corresponding metal 
complexes yielded information which was important in the 
development of an analytical method for the speciation of these 
antibiotic-metal complexes. The retention times obtained also 
reflected different binding sites in the case of the Fe(II) 
ion. The lability of these complexes is also discussed.
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TABLES.
INTRODUCTION
A. Uses and importance of the Tetracycline antibiotics
The tetracyclines were discovered as a result of a 
deliberate search for new antibiotics [1] The basic ring 
structure of these antibiotics is indicated in structure (I). 
The first member of the group, namely chlorotetracyclme 
(Ila), was isolated from culturesof S t r e p t o m y c e s  A u r e o f a c i e n s  
by Duggar in 1984 [1] This was followed by the isolation 
of oxytetracyclme (III) from s t r e p t o m y c e s  R i m o s u s  
Tetracycline (lie) has also been isolated from soil cultures, 
but is usually produced semi-synthetically by the catalytic 
hydrogenation of chlorotetracycline [2].
The basic action of tetracyclmes is an interference in 
protein synthesis. The tetracyclines are bacteriostatic agents 
that act by blocking the attachment of transfer RNA to 
ribosomes, thus interfering with protein synthesis The 
tetracyclines have a wide range of activity, inhibiting Gram- 
positive and Gram-negative organisms. Resistance to 
tetracycline is a slow process which is not often seen during 
treatment. When taken orally all the tetracyclines are readily 
absorbed and widely distributed in tissues. Due to their wide 
antibacterial activity the tetracyclines can be used in a 
greater variety of infections than any other antibiotics. 
Tetracyclines are widley used in the treatment of infections 
of the respiratory tract, infections of the urinary tract and
in the treatment of syphilis, gonorrhoea, anthrax and 
actinomycosis The tetracycline drugs are relatively non­
toxic, but they are nevertheless liable to cause a number 
of disturbing side effects, partly because they are irritant 
drugs Gastrointestinal disturbances such as nausea, vomiting 
and diarrhoea are common.
B. General Tetracycline Chemistry.
I. Structure of the Tetracyclines.
In 1953 the structure of these antibiotics was determined
and found to have the general structure (II). Tetracyclines
are large molecules based on a four-membered ring system (I)
and possess a variety of functional groupings The structure
of oxytetracyclme (III) was established in 1952 by
interpretations of chemical degradations supported by
ultraviolet and infrared spectra and pK measurements.a
Oxytetracyclme hydrochloride was synthesised totally by 
Muxfeldt in 1968 [3].
II Physical Properties of the Tetracyclines
The tetracyclines are essentially weak bases, insoluble 
in water and soluble in organic solvents, chlorotetracyclme 
(11 a) being the most unstable and demeclocycline (He) the least 
unstable The tetracyclines are stable in their corresponding salt 
forms at acidic pH's; but at basic pH1s they either hydrolyse, 
rearrange or undergo ring opening
2
CONHR5
(II)
( I I I )
^ 3)2
CONHo
(IV)
(V)
Approved
names(s) Ri R2
Substituents
R3 R4 R5
(a) Chlortetracycline Cl -ch3 OH H H
(b) Oxytetracycline H ch3 OH OH H
(c) Tetracycline H ch3 OH H H
(d) Demethyl chiortetracycline 
Demeclocycline
Cl H OH H H
(f) Pyrrolldinomethyl tetracycline H 
Rolitetracycline
ch3 OH H (1) below
(h) Methacycline 
6-Methylene 
Oxytetracycline
H CH2 OH H
(j) Lymecycline 
Tetracycline L- 
methylene lysine
H ch3 OH H (2) below
(1) Sancycline H H H H H
(m) Minocycline n(ch3 )2 H H H H
(n) Doxycycline n(ch3 )2 ch3 H OH H
(0 ) Clomocycline Cl ch3 OH H c h2oh
(p) 4-Epianhydrotetracycline H ch3 H H H
(q) 4-epitetracycline H ch3 OH H H
(r) Anhydrotetracycline H CH3 H H H
(s) Pemmocycline H OH ch3 H (3) below
(t) 6-deoxy-5-oxytetracyclme H H ch3 OH H
(u) Anhydro-chlorotetracyclme! Cl ch3 h H H
(v) 6-demethyl tetracycline H H OH H H
Table 1 Names of Tetracyclines and their degradation products 
(refer to structure (II)).
-CH2NÍ
\  '
—CH7NH(CH?)z.C h CO on 
IH2
-CH2NHCH[(^ "^ )C0NH
6Many authors agree that tetracycline hydrochloride exhibits
three pK values in the 1 - 10 pH range. There is however lack 
a
of agreement as to the sites with which these phenomena are
associated Stephens et ai [72]determined pK values where
a
pK^ = 3 30, pl<2 = 7 68 and pK^ = 9 69 and assigned them to the
-OH group at the - N I ^ C H ^  group at C^ and the 3-diketone
moeity at C^o,C11 and ^12 resPectlve^y Leeson et ai [82],
however proposed a reversal in assigments for pl<2 and pK^ based
upon a comparison with values obtained for the quaternary salt.
These conclusions were supported by Garrett [83]. On the other
hand Rigler [84]has exploited NMR chemical shift information
to determine results in agreement with Stephens et ai [72]. Smyth et ai
[4],however,provide evidence for a fourth pK value and assign
a
it to the -OH group at C ^ .
III. Chemical Reactions of the Tetracyclines.
Tetracyclines,with their variety of functional groups» 
undergo extensive chemical reactions including epimerisation, 
dehydration , oxidation, reduction, hydrolysis, elimination 
and acetylation to name a few Epimerisation and dehydration 
reactions occur extensively in the isolation [5]>purification 
and formulation of the tetracyclines. Epimerisation and 
dehydration lead to inactivation of the antibiotic. The 
dehydration reaction lends itself to an E2 process and is 
promoted by the tertiary benzylic nature of the -OH group at
7C c and its antiperiplaner trans relationship to the H atom at 0
Cc . One of the canonical forms of the enolizable B-dicarbonyl 
ba
system present at and has a double bond in the C ring 
Thus dehydration leads to aromatization of the C ring.
Epimerisation of the tetracyclines involves the dimethyl amine 
function at which is axial and subject to 1,3-diaxial 
nonbonded interaction with the C ^ a “OH group (also axial)
Being a to the resonance stablised 3-tricarbonyl system in ring 
A, the dimethylamino function can relieve the strain by 
epimerisation This reaction, which occurs most rapidly in 
aqueous solution of pH 3 - 5, results in an equilibrium mixture 
consisting of nearly equal amounts of the two isomers.
Chemical reduction and oxidation have been carried out 
on the tetracyclines and the products of the reactions 
identified The reduction and the degradation of 
oxytetracycline hydrochloride with zinc in glacial acetic 
acid gives two products Chlorotetracycline (11 a) and tetracycline 
(lie) also undergo a similar reduction establishing a general 
reduction common to a given moeity of the parent tetracycline 
molecule.
IV Electrochemical reductions
Doskovil and Vondracek [6] were the first to investigate 
the reduction of chlorotetracycline by polarography The reduction 
appeared to take place in two 2-electron waves. In buffered 
solutions, the reduction took place throughout the pH range, 
but at acid pH the polarographic waves were ill-defined. The 
reduction of oxytetracycline (III) was shown to take place in
8a similar manner to that described for chlorotetracycline (11 a)• 
Again the total reduction appeared to take place in two 2-electron 
waves which were attributed to the reduction of the two 
unsaturated carbonyl systems in the molecule Overall, the 
polarographic waves were complex and largely dependent upon 
pH and nature and concentration of the buffer used,and lastly 
the concentration of the antibiotic
Doskocilova [7] was the first to attempt to interpret the
reduction waves and to coordinate these with specific functional 
groups. These results showed that tetracycline (lie) was reduced 
at approximately the same potentials as chlorotetracycline (11 a) 
and oxytetracycline (III) and in two apparent reductive steps.
The reduction waves were complex,consisting of a number of
indistinctly defined pH dependent waves which did not appear 
to correspond to a similar two electron reduction Maxima 
complicated these reduction waves even further Certain portions 
of the first wave were shown to be characteristic of adsorption.
The second wave was characteristic of one whose limiting current 
results from a chemical reaction In conclusion,Doskocilova 
assigned the more positive reduction potential to the A ring 
of the antibiotic and the more negative reduction potential 
to the conjugated carbonyl system at the C ^  - C ^  and C ^  
positions All these conclusions were on the basis of polarographic 
wave analysis and no attempt was made to identify products 
Caplis [ 8] concludes that the polarographic response in 
buffered aqueous solution (Clarke-Lubs and 0.1 M KCL) is complex.
9The total polarographic response was irreversible and indicated
that the reductions involved preceeding and/or subsequent chemical
protonation reactions. The total limiting current and half-wave
potentials were pH dependent and related in some manner to the
second pK value for tetracycline hydrochloride and the A ring 
a
The first reduction wave was complex at acid pH and involved 
more than one single reduction in the molecule The reduction 
of the protonated tertiary amine moiety was in part 
responsible for this wave. The remaining current of the first 
wave may be due to the reduction of the protonated product from 
thee last wave. The total reduction at acid pH probably involves 
a transfer of five electrons. The tetracyclines appear to be 
surface active and all reductions appear to take place while 
the compound is adsorbed at the electrode surface Since the 
whole tetracycline system is so complicated in an aqueous system, 
a similar non-aqueous medium was used by Caplis for studying 
the electrochemistry of the antibiotic The non-aqueous systems 
used were acetomtrile,dimethylformamide and dimethylsulphoxide. 
Using acetomtrile the current-concentration (i-c) curves were 
non-linear and the current appeared not to be diffusion controlled. 
In dimethylformamide,the general shape of the polarograms, 
the i-c relationship and the electrocapillary behaviour were 
similar to previous observations made in acetomtrile. In 
dimethylsulphoxide,however,the total current appeared to be 
diffusion-controlled.
10
C. Tetracyclme-metal complexes.
The tetracycline antibiotics form complexes with many metal 
cations [9], and these complexes show enhanced alkaline 
stability. However,the site of complex formation is not established 
Many proposals have been put forward However, it is the A 
ring of the BCD chromophore moiety of the antibiotic which 
are thought to be the most likely sites of complexation for 
metallic species [10, 11, 12].
More specifically the proposed sites of conplexation are 
at (a) the C^q -C^ ketophenol moiety [4], (b) the C ^ - C ^
3-diketone moiety [11], (c) the C^ dimethylamine and the C^ 
or C ^ a hydroxy moieties [13], (d) the C^-C^ tricarbonyl methane 
moiety [11] and (e) multidentate combination of the 
3-diketone and C^-C^ tricarbonyl methane moiety achieved through 
folding of the molecule along C ^ - C ^  axis [15].
Spectroscopic measurements on solid complexes [16] indicate 
that the molecules coordinate through oxygen and there is some 
additional evidence from solution studies that the dimethylamine 
group is not involved [14]. According to Albert [17] the nature 
of tetracycline complexes in solution depends on its pH and 
on the nature of the cation itself which could be a deciding 
structural factor Metal-tetracycline complexes are important 
because they are thought to be linked to the mode of action 
of antibiotics.
In view of their novel polycarbonyl system (containing 
a- and peri- hydroxy groups, a-carboxyamido and a-dimethylamino 
functions) it would be surprising indeed if these antibiotics
11
r
Metal 11c Oxytetracyclîne
cation Log K Log K Log K?
Fe(III) 9.1 7.2 22.0
Cu(II) 7.2 5 0 12.2
Ni(II) 5.8 4.8 10.6
Fe(II) 5.6 4.8 10.4
Co(II) 5.1 Precipitation 9.0 (approx)
Zn(II) 4.6 Precipitation 8.0 (approx)
Mn (II) 4.3 3.7 8.0
i
K = 1 1  complex 
11
K = 1 2  complex
K$ = the product of all the partial constants (of which a 
divalent ion has two and a trivalent ion has three)
TABLE 2.
Stability Constants of oxytetracyclme hydrochloride and 
various metal ions.
did not form chelate complexes with metallic ions [17]. Albert
[17] has calculated stability constants for oxytetracycline 
metal complexes (Table 2) and has stated that chelation is likely 
to play a part in the mode of action of these antibiotics “because 
substances with constants of such magnitude could not fail to 
compete with metals in the tissues" Conover [12] draws the 
following conclusion about tetracycline-metal complexes that 
"the site of metal combination with the antibiotics must be in 
the B -diketone moeity'.'
It has also been observed that tetracycline forms its most 
stable complex with Al(III) [18], with Fe(III) being the second most 
strongest bonding metal [18]. Albert [17] has pointed out that
higher than 1 1 metal to ligand complexes exist with divalent 
metal ions.Different metals do not necessarily form different 
type complexes but rather 1 2 or 2 1 (metal antibiotic) complexes 
at different concentrations. Existence of 1 2 metal antibiotic 
complexes have been reported at high pH's.
In 1950 Loomis [85] observed that chlorotetracycline (Ila) 
uncoupled mammalian aerobic phosphorylation thus inhibiting 
the formation of ATP which is the primary source of energy for 
all cell functions. This observation suggested that tetracycline 
might act by inhibiting the action of important compounds of 
the electron transport system and the process of oxidative 
phosphorylation [11]
Many possible modes of tetracycline action have been suggested 
but one is of particular interest. It has been 
suggested that tetracyclines uncouple aerobic phosphorylation,
13
that is they inhibit the formation of ATP, (which is as stated 
earlier a primary source of energy for cellular functions) 
without affecting oxygen consumption by interaction with magnesium 
bound to an enzyme. With regard to aerobic phosphorylation.
It has been pointed out that manganese is essential for 
this process, so if the maganese was bound to the antibiotic 
it could very easily interupt this biological process.
A study of the inhibition of alanine dehydrogenase by 
oxytetracycline (III) and concluded that a metal chelate of 
oxytetracycline is the actual inhibitor. These studies suggest 
the importance of ternary binding in the mechanism of action 
of these antibiotics. As well as affecting living cells in 
this way, the tetracycline that form complexes with calcium 
are deposited in all newly calcifying tissue. In this way they 
can be used to label growing tissue In conclusion tetracycline 
metal complexes are known to play a part in (1) mineralising 
tissues (n) antibacterial activity and ( m )  gastrointestinal 
absorbtion [19]
D. Analytical Methods of Tetracyclines.
The most commonly used offical method for determining 
tetracycline potency is the microbiological assay procedure.
In addition to the microbiological procedure, numerous other 
methods include non-aqueous titrimitry, ultraviolet spectroscopy, 
fluorimetry, polarography and chromatography In determining 
the choice of method of analysis, sensitivity, selectivity 
and specificity must be taken into consideration
14
I. Microbiological Assays.
Tetracyclines are commonly assayed by microbiological 
techniques when a suitable chemical method is not available 
[20] or when the sensitivity of such a method has been shown 
to be inadequate. However microbiological analysis is of limited 
specificity, that is, it cannot distinguish between tetracycline 
(lie) and its degradation products,hence the chemical purity 
of the antibiotic cannot be ascertained. Microbiological 
analysis is also extremely time-consuming.
Tetracyclines are produced by fermentation processes and 
as a result most of the standard methods of analysis are
nucrobiol-ogic-al [21]. Th-e procedures are useful fortireasunng activity 
against a specific test organism but do not tell the analyst 
anything about the chemical purity of the medicine. On the 
basis of these tests it is difficult to carry out any process 
development work to increase the purity of the yield of the 
— ^tetracycline produced.
The standard procedure for microbiological assaying are 
outlined in the British Pharmacoepia [22]. The potency of a 
sample of any tetracycline is determined by comparing the dose 
which inhibits the growth of a suitable susceptible microorganism 
with the dose of a standard preparation of the relevent 
tetracycline which produces the same degree of inhibition.
I I  F l u o n m e t r y
The fluoresence properties of the tetracyclines have been
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[23]. Numerous procedures based on fluoresence have been devised 
for the quantitative determination of these antibiotics in 
biological samples in order to study their pharmokinetic properties
[24].
Kelly et ai,[23] devised an analytical method for the 
evaluation of a therapeutically useful combination of three 
tetracyclines namely, tetracycline (He), chlorotetracycline 
(11 a) and demethylchlorotetracycline (IId) utilising fluorimetry. 
This fluorimetric procedure could determine concentrations of
0.1 to 0.2 mg/1 of each antibiotic in the presence of the other 
two. The three tetracyclines were combined in the ratio 1 1 0.1 
to form a triple tetracycline, with this, advantage is taken 
of the difference shown by each component in reactivity towards 
acids and bases.
used for the study of these compounds since their discovery
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In this procedure, chlorotetracycline (II a)is determined by 
conversion to the fluoresent isochlorotetracycline (VI), 
tetracycline is then determined in the same aliquot by conversion 
to anhydrotetracycline (Hr) and measurement of the fluoresence 
of an aluminium complex of this derivative. Demethylchlortetracycline 
(IId) is determined by difference application of a method which 
measures total tetracyclines [25].
Kohn [25] describes a method of analysis of the Tetracyclines 
by extraction of fluoresent complexes, whereby the chelation 
properties of the antibiotics are made use of. Firstly an attempt 
to use the strong fluoresence of a Ca(II) chelate for determinations 
in tissues was found to be insensitive due to high background 
fluoresence. Extraction of the fluoresent species into organic 
solvents was therefore attempted and ethyl acetate was selected 
because of its specificity for the tetracyclines. Thus a procedure 
was developed which combined the use of fluorimetry and complexation 
extraction to yield a highly sensitive,specific method of analysis 
for the tetracycline antibiotics, with the exception of 
oxytetracycline.
UI. Polarography
Polarographic analyses of the tetracycline antibiotics 
was first reported in the early 1950's A survey of the analytical 
methods of polarography [86] used for the tetracyclines shows that 
it is a good analytical tool for such analysis. Many of the 
earlier attempts to develop methods showed that the f o r m  and relative 
heights of waves obtained was complex,and depended upon pH,nature
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and composition of buffer, composition and the concentration 
of the antibiotic [26]. Hetman [26,28] studied these antibiotics 
at pH 4.7 by alternating current (ac) polarography and found 
that three waves were produced. Chlorotetracycline (Ila) and 
oxytetracycline (III) have been determined in mixtures by direct 
current (dc) polarography. Hetman [28] has reported a 
differential polarographic method for the determination of 
tetracycline (lie) in urine using a supporting electrolyte of
0.1 M barbitone-0.1M Li cl solution-40% Methanol, pH 4.7. In 
this medium tetracycline gave rise to three waves at -1.20v,
-1 30V, -1.50V Similar behaviour has also been observed for 
tetracyclines in a variety of other supporting electrolytes 
such as Clarke and Lubs buffer dH 4.1, and 0 1 M acetone buffer 
pH 4.0, but have been found to be inferior to the baritone buffer 
for analytical purposes.
Caplis et ai.[29] developed a method for the analysis of 
tetracycline (He), chlorotetracycline (Ila) and oxytetracycline 
(III) by alternating-current (ac) polarography This method 
agreed favourably with standard microbiological assays and was 
shown to be applicable to medicináis containing these antibiotics 
This method was more sensitive and faster than direct-current 
(dc) polarography Qualitative and quantitative determination 
of oxytetracycline in the presence of chlorotetracycline (Ila) 
appears to be possible. Examination of the polarograms obtained 
for each of them showed that only the peak obtained at -1.65V 
showed sufficient sensitivity in phosphate buffer at pH 4 1 for
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quantitative determination. Qualitative identification of the 
antibiotic can be made easily at pH 4 1 due to the fact that 
chlorotetracycline (Ha) shows as additional response at -1.76V 
which is not exhibited by oxytetracycline (III) Alternating 
current (ac) polarography thus offers itself as a unique analytical 
tool for the analysis of tetracyclines.
Chatten e t  a l  [30] systematically investigated the effect 
of pH and buffer systems on the reduction of these antibiotics 
at the dropping mercury electrode (DME) and then applied 
optimum conditions to their quantitative determination in 
pharmaceutical dosage form It was concluded that the boric 
acid-sodium borate buffer (pH 7.2-9.6) was the optimum buffer 
system to achieve a well resolved limiting current plateau for 
the tetracyclines. The optimum pH for tetracycline (lie), 
oxytetracycline (III) and chlorotetracycline (11 a) were shown to 
be 7.75, 8.20, and 7.95 respectively so the technique of direct- 
current polarography can be applied satisfactorily to the 
tetracycline antibiotics.
Oil iff and Chatten [31] showed that two well defined waves
resulted at pH 4.0 for all tetracyclines studied in an acetate
buffer. Concentration changes appeared to have no effect on
the peak potential (E^) values of either main wave Conditions
were established so that only one buffer system was required 
for all seven tetracyclines. The reversibility of the second wave 
is ideal for use in analytical alternating-current polarography 
At pH 4 0 however the precision of the second wave is less than 
that of the first wave
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Cutie et a i [32] employed a modified differential pulse 
polarographic technique to analyse tetracycline (lie), 
minocycline (Ilm) and demeclocycline (lie) and two mixtures 
of these compounds. A pH of 4.3 and an acetate buffer were 
found to be the optimum conditions for the polarographic peak 
separation and quantitative analysis.
Gochsberger et ai [33] reported the use of differential 
pulse polarography in the detection of tetracycline and a number 
of its derivitives. They [34] also describe the use of differential 
pulse polarography for detecting anhydrotetracycline (lie) in 
the presence of epianhydrotetracycline (Up), (both degradation 
products of tetracycline which result spontaneously), and for 
following the conversion of the former compound to the latter.
An acetate buffer of pH 4 31 was used.
Kozloz et ai. [35] describe a method of determination of 
the antibiotics tetracycline (lie), chlorotetracycline (11 a) 
and 6-de-oxytetracycline (lit) and the degradation product 
anhydrotetracycline by voltammetry at the interface of two immiscible 
electrolyte solutions at concentrations ranging from 
0 Immol.dm -^he immiscible electrolye solutions being 10 mm HCL 
and nitrobenzene. Pharmaceuticals containing tetracycline could 
be analysed with an accuracy of 3% by this method.
IV. Spectrophotometry [36].
A simple procedure for the assay of chlorotetracycline 
(11 a) was described by Levine et al, based on conversion to 
anhydrous chlorotetracycline (11 a) by heating with acid followed
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by spectrophotometric determination at 440 nm The method took 
no account of course of impurities such as epimers and isomers 
which would be measured with chlorotetracyclme (Ha) and this 
may in part account for some discrepancies observed between 
this method and a microbiological method when applied to 
formulations In 1955 three spectrophotometric ( or 
cclourimetric ) methods were described which were then 
in current use for the assay of tetracyclines One method (for 
tetracycline (lie) and chlorotetracyclîne (lia)) was the method 
of Levine e t  ai,another (for tetracycline, chlorotetracyclme, 
and oxytetracycline) was adapted from the work of Monastero
e t  a i , [88] involving colour development with ferric 
chloride followed by absorbance measurement at 490 nm and the 
third (Oxytetracycline (III) and tetracycline (lie)) involved 
direct spectrophotometric measurement of alkaline solutions 
at 380 nm. No details were given of possible interference from 
accompanying impurities.
Hiscox [89] described a modification of the method of Levine e t  
ai [87]inwhich measurements of absorbance were made at a number 
of wavelengths. A more specific way of analysing tetracycline 
(lie) and chlorotetracyclme (11 a) in the presence of each other 
and of oxytetracycline (III) was described by Chiccarelli et ai [90] 
involving conversion of chlorotetracyclme (11 a) to 
i sochlorotetracycline (VI) on heating at pH 7.5 based on the 
stability of tetracycline (lie) under these conditions and the 
stability of isochlorotetracyclme (VI) in hot acid Thus when 
a mixture of chlorotetracyclîne (lia) and tetracycline (lie)
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is first heated at pH 7 5 and then with acid the tetracycline 
(lie) is converted to anhydrotetracycline (Ilr) leaving 
chlorotetracycline (11 a) in the form isochlorotetracycline (IV) 
which has little or no absorbance at 440 nm. For the analysis 
of tetracycline (He) containing small amounts of chlorotetracycline 
(11 a) the solution is first heated at pH 7 5 then in acid the 
absorbance reading at 440 nm is due to anhydrtetracycline 
(Hr) derived from tetracycline (lie). Conversely chlorotetracycline 
(11 a) (containing small amounts of tetracycline (He)) is analysed 
by the method of Levine et ai [87] but with a blank correction 
(for tetracycline (He)) obtained by heating an aliquot at pH 
7.5 prior to treatment with acid Oxytetracycline (III) is 
converted to colorless apooxytetracyclines in the acid conditions 
and thus interfers with neither analytical procedure. Cruceanu et ai 
[91] analysed tetracycline (lie) in pharmaceutical formulations 
by simply measuring absorbance 355 nm in dilute acid solutions.
Good agreement with microbiological results was claimed A
specific assay for 6-demethyl tetracycline (Uv) present in trace
amounts in samples of demethylchlorotetracycline (IId) has been
developed by Chiccarel1i[90] based on a reaction of demethylchlorotetracycline
(IIv) with 4N nitric acid at 100°, to give a product with enchanced
absorption at 425 nm. Under the same conditions
demethylchlorotetracycline (IId) is unstable (as are other
tetracyclines (lie)) and gives a product having low absorbance
at 425 nm. Two methods were described one involving direct
spectrophotometric measurement of the colored product, the other
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having an intermediate extraction of the colored material with 
n-butanol prior to spectrophotometric quantification Chatten 
and Krause [92] have described the quantitative analysis of various 
tetracyclines in pharmaceutical formulations using colorimetric 
measurements of complexes formed between the tetracyclines and 
thorium Janik and 011at [95] have recently described a 
spectrophotometric method for oxytetracycline (III), based on 
the formation of complexes with cerium.
Most of the spectrophotometric methods described so far 
lack the ability to differentiate between the tetracycline being 
assayed and closely related impurities or degradation products, 
in particular epimers. Total anhydro content (anhydrotetracycline 
(Hr) and a pi anhydrotetracycline (Up)) of tetracycline samples 
can be readily measured spectrophotometrically ( Walton et a i
[96] ) but to determine either of these separately requires 
prior chromatographic treatment A spectrophotometric method 
(absorbancy ratio method) for the assay of epi tetracycline (Ilq) 
in tetracycline was developed by McCormick et ai [93] based on small 
differences in the absorbances of tetracyclines and their epimers 
in 0.1 M sulphuric acid solution at 254 and 267 nm. This method 
has been applied to studies of the influence of pH and buffer 
strength on epimerization, to studies of the kinetics of the 
reaction, to investigations of the role of metals and of other 
substituents, and to studies of the effect of urea on the 
epimerization ofc hlorotetracyclme (11 a) by ultraviolet light.
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V. Chromatography.
Thin layer chromatography (TLC),paper chromatography and 
column chromatography followed by ultraviolet spectroscopy have all 
proved laborious and generally not sufficiently sensitive or 
precise for the tetracycline antibiotics [37].
In general, tetracyclines are not sufficiently volatile 
or thermally stable to be suitable to analysis by gas liquid 
chromatography [20]. Gas chromatographic methods have been 
used, but have involved derivatisation and extraction procedures 
that are too time-consuming to be used in routine analysis.
Tetracyclines have proved to be a difficult group of molecules 
to analyse by high performance liquid chromatography (HPLC). 
Problems in the HPLC analysis of the tetracyclines arises from 
the large number of polar functional groups which the molecules 
posess These functional groups tend to adsorb strongly on 
the silanol sites of support materials (including the residual 
silanol sites of many chemically bonded and polymer coated 
supports) and give rise to badly shaped peaks. Furthermore 
tetracyclines are unstable in solution and tend to epimerise 
to the 4-epi-form. However methods have been developed to overcome 
these problems,and now HPLC is capable of rapidly selectively 
and accurately determining tetracyclines,and can be used to 
supplement results obtained by microbiological testing of potency, 
or even replace it. Tetracycline reference standard normally 
contains about 4% of the 4-epimer (Ilq), which is almost inactive 
and consequently even the pure standard has only 96% purity. 
Epimerisation tends to occur faster at pH 2-6 If tetracycline
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(lie) is exposed to heat (for example) during storage it tends 
to degrade to form anhydrotetracycline (Hr) and 
4-epianhydrotetracycline (IIp). It is therefore important for 
accuracy and reasons of safety to be able to separate the components 
chromatographically rather than express a microbiological assay 
that expresses an overall potency.
HPLC methods used for the analysis of the tetracycline 
antibiotics can be divided into two groups those employing 
ion exchange materials and those employing reversed-phase bonded 
materials. Comparing both methods it would appear that using 
reversed-phase bonded materials gave better performance in terms 
of plate number, plate height and resolution [38].
(a) Ion-exchange separations
Loeffer [94] described a method of separation of oxytetracycline 
(III) and its impurities using a Zipax SCX column and 0.10 M 
EDTA, 0 1 M KH2P04 as the eluant, pH 7.6.
Butterfield et a i [39] described a method of analysis for 
tetracycline (lie), epitetracycline (Ilq), anhydrotetracycline 
(Hr) and epianhydrotetracycline (lip) using a pellionex CP column 
with the mobile phase being 0 1 M Na+ , 0 002 M EDTA in water 
ethanol (70 30) pH 4 6, and a method to separate
demethylchlorotetracycline, chlorotetracyclme, epichlorotetracyclme, 
tetracycline, epitetracycline, and minocycline using a Zipax 
SCX column and a mobile phase of 0 05 M NO^ and 0.004 M EDTA 
in H^0 ethanol (90 10). Two years later the same experimentalists 
[40] described a method of separation of rolitetracycline (11 g ) 
and tetracycline in rolitetracycline preparations using a pellionex
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CP128 A column and a mobile phase of 0 1M Na, 0.03M EDTA in 
water:ethanol (60 40) pH 4.4.
Lotsher et ai.[41] described a method of separation of 
oxytetracycl me, tetracycl me, doxocyclme (I In) and 
chlorotetracyclme (11 a) using a Pellionex SCX column and a mobile 
phase of 0 1 M NH^NaHPO^, pH 8 2.
Chevalier et ai.[42] suceeded in separating tetracycline 
(lie), epitetracycline (Ilq) and pemmocycline (Ilg) using a 
Pellionex SCX column and a mobile phase of 00TMEDTA in methanol - 
water gradient pH 5.0
Lindauer et ai [43] described a method of separation of 
epianhydrotetracycline (Up) ^nd epitetracycline (Ilq) in tetracycline 
(lie) preparations using a Zipax SCX 35 column with sarturared 
EDTA pH 7.0 as the eluant.
Eksborg [44] described^ a reversed-phase ion pair 
chromatographic separation of tetracyclines on a LiChrosorb 
NH^column The tetracyclines were retained as lon-pairs with 
1-hydroxy-2,3-dnsobutylbenzenesulphomc acid (HIBS) dissolved 
in mobile phases comprising of acetomtrile in 10 M phosphoric 
acid. This method proved to be a suitable technique for the 
isolation of tetracyclines.
Eksborg et a i  [45] again chromatographed tetracyclines 
on alkyl-bonded silica supports using reversed-phase ion pair 
chromatography in mobile phases of acetonitrile-water in phosphoric 
acid.
Murrot et ai [46] described a method to separate oxytetracyclme 
(III) and its degradation products using a LiChrosorb RP -8 column
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and a mobile phase of tetrabutylammonium hydrogen sulphate (TBA) 
in water acetomtrile (92 8 and 80 20). This method has
proved useful in quality control of raw materials and commercailly 
available vetinary preparations.
(b) Reversed-phase separations.
Ascione et ai [47] described an automated liquid 
chromatographic method to determine the tetracycline antibiotics 
This method was applicable to crystalline tetracyclines and
their various pharmaceutical dosage forms. This method was 
simple and rapid to perform
Tsuji et ai [48] described a liquid chromatographic method 
for the determination of these antibiotics requiring no
derivatisation or gradient elution. The method involved using 
a Zipax HCP column and a mobile phase of 0.001 EDTA, 0 01 M 
H^PO^ in water methanol (87 13, V/V), at pH 2 5, and separated 
tetracycline (lie), anhydrotetracycline (Hr), chlorotetracycline 
(11 a) and doxytetracycline (IIn) within thirty minutes, the
relative standard deviation was 1.02% and the method is sensitive 
to approximately 10 nanograms tetracycline per sample injected.
White et a i [49] described a method of separation of 
oxytetracycline (III), doxotetracyclme (Iln),
demethylchlorotetracycline (lid) and tetracycline (lie) using 
an 0DS-SIL-X-I (Perkin Elmer) column and a mobile phase of 0 005 M 
EDTA, 0 05 M ( N H ^ C O ^  m  water‘methanol (92 8 ), pH 7 5.
Knox and Jurand [50] separated tetracycline (lie), 
epitetracyclme (Uq), anhydrotetracycline (Hr),
27
epianhydrotetracyclme (Up) and chlorotetracyclme (11 a) on 
a TMS bonded Partisil column and mobile phase of 0 1M HC10^ 
in water: acetomtrile (85 15 to 70 30) pH 1.5-2.0.
Knox and Pryde [51] separated tetracycline (lie), 
epitetracycline (I Iq), chlorotetracyclme (11 a)» 
epianhydrotetracyclme (I Ip) and anhydrotetracycline (Hr) on 
a TMS bonded WLCU silica gel and a mobile phase of 0.1M HC10^ 
in water acetomtrile (85 15 and 70 30) pH 1.5-2 0.
Tsuji and Robertson [52] described a method of separation 
of tetracycline (lie), epitetracycline (I Iq), chlorotetracyclme 
(11 a), epianhydrotetracyclme (Up) and anhydrotetracycline 
(Hr) using a pBondpak C^g column and a mobile phase of 0.02M 
phosphate buffer in water acetomtrile gradients, pTT2.5.
De Leenheer and Nelis [53] suceeded in separating 
Oxytetracycline (III), tetracycline (lie), doxycycline (IIn) 
and tetracycline (IIn) with LiChrosorb Cg column and an eluant 
of citrate-phosphate buffer in water.acetomtrile (65*35), pH 2.1.
Chevalier et ai.[54] using a micropak CH column and a mobile
phase of 0.001M EDTA, 0.02M phosphate buffer in water-methanol 
(gradient 25-50« v/v methanol), succeeded in separating tetracyclne
(He), epitetracycline (Ilq), chlorotetracyclme (Ha), 
pemmocycline (IIs).
Sharma e t  a i [55] suceeded in separating Oxytetracycline 
(III), tetracycline (lie) and chlorotetracyclme (11 a) in extracts 
of urine and plasma using a yBondpak C^g column and an eluent 
of 0.01M NaH^PO^in water acetomtrile (60*40),pH 2.4.
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Mack and Ashworth [56] described a method of separation 
of epitetracycline (Ha), oxytetracycline (III), 
epianhydrotetracycline (lip), tetracycline (lie), doxycycline 
(Iln), anhydrotetracycline (Hr), chlorotetracycline (11 a), 
methacycline (Ilh) and minocycline (Ilm) using a Vydac RP C^g 
column and an eluent 1mM (NH^EDTA 0 05M dimethyl amine in 4% 
isopropyl alcohol.
All and Strittmatter [57] have described a method of separation 
of epitetracyclme (Ilq), tetracycline (lie), anhydrotetracycline 
(Hr) and epianhydrotetracycline (lip) using a ODS-SIL-X-I column 
and a mobile phase of waterracetomtrile'perchloric acid 76 26 1.8 
or 61 37 1.8),pH 1.2.
Knox et ai.[58] realised that the most sucessful methods 
of high performance liquid chromatography employed reverse- 
bonded packing materials and aqueous-organic eluents.
Under these conditions,the bonded packing materials are unstable 
so that column life can be short They developed a method which 
gave highly efficient separations in the presence of EDTA under 
mildly acidic conditions pH range 3-5. The general performance 
is further improved by the addition of salts. Two organic modifiers 
namely acetomtrile and dimethylformamide were used. Good 
quantitation of the tetracyclines was obtained and oxytetracyclme 
(III) can be directly assayed in solution
Nelis et a I [53] described^ chromatographic method of 
separation of tetracyclines on a Cg reversed-phase material.
Optimal performance was obtained using eluents containing organic 
acids at relatively low pH's. Maximum retention occurred at 
pH 3.3. Separation of seven tetracyclines resulted from a 
LiChrosorb RP-8 column and an eluent of 0 1M citric acidtacetomtrile
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(76 24 v/v).
Muhammad et a i [59] describe an assay for tetracyclines 
and its degradation products without a solvent gradient system 
A microparticulate phenyl column with a gradient of 12-22% 
acetomtrile in 0.2M phosphate buffer at pH 2.2 was used This 
assay provided a rapid sensitive, simple and quantitative method 
for the simultaneous determination of impurities in tetracycline
THEORY
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The theory concerning ultraviolet spectroscopy is reviewed
in standard texts [60,61]. It is only shown here how it can
be applied to determine pK values, and to ascertain the sites
a
at which metals might be binding.
The dissociation of a monobasic acid can be represented by
Ka +
HA + H20 X  H3° + a H )
The acid dissociation constant (K ) of this equilibriuma
is related to the pK value by,
a
PKa = -1o9lOKa = -1o9l0 V  *A~ <2)
a HA
A. Ultraviolet Spectroscopy
where a represents the activity of the various species At
-5
the concentrations worked with here (10 M) the activity of 
the various species can be approximated to concentration.
Equation (2) can be rewritten in the form of the Henderson- 
Hasselbach equation
pKa = pH + log1Q HA]
A T  (3)
By the Beer-Lambert Law,
A - cel (4)
where A is the absorbance, e the absorption coefficient, c the 
concentration and 1 the path length in cm.
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The concentration of the species in question is related 
to their relative absorbances through the Beer-Lambert law 
yielding,
(CHA + CA‘) = eHACHA1 = eA'CA_1 ^
and by substitution into equation (3)
pK = pH + log A "
e
10
(6)
when eA - >>CHA or
pKa = pH + log1Q _!---
eHA ' e (7)
If one assumes that the sum of [HA] and [A“] remains constant, 
then the pK of a monobasic acid can be determined mathematically 
from measurements of the absorbances of HA, A" and a mixture 
of the two at a suitable wavelength and substitution into equation
(6) or (7).
These relationships can also be expressed graphically where
a plot of A versus pH at a selected wavelength will yield
a sigmoidal curve, the midpoint of which corresponds to the
pK value a
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ii
Description Region of
electronic spectrum
From a bonding orbital in the ground 
state to an orbital of higher energy
Vacuum ultraviolet 
region (125 nm)
★ *
(a) o  +  o  - (between a orbitals)
(b) 11 + 7r* (between ^ orbitals) Ultraviolet region 
(180 nm)
From a nonbonding atomic orbital to 
a high energy molecular oribital
(a) n Near ultraviolet and 
visible regions
*
(b) n ■* o Far/near ultraviolet 
regions
From an orbital in the ground state 
to one of very high energy in the 
direction of the ionisation of the 
molecule
Vacuum ultraviolet 
region
TABLE 3
Description and region of spectrum of electronic transitions 
using ultraviolet light
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An analysis of the spectra obtained for a monbasic acid 
will yield a wavelength at which = e^-. This is known as 
the isosbetic point, and although its presence cannot always be 
taken as definite evidence for a single equilibrium taking place, 
its absence confirms the existence of overlapping equilibria, 
and in cases such as this the treatment mentioned above is 
invalidated
The absorbances ocurring in the ultraviolet region 
are due to various transitions of valence electrons to levels 
of higher energy. Different type of electrons, i.e. cr, n, n 
give rise to different transitions and hence different spectra. 
Table 3 is a summary of these electronic transitions. These 
transitions discussed are characteristic of the substance being 
analysed. Substitution of structural changes to the compound 
result in changes in the wavelength and in the intensity of
the absorbtion bands. Wavelength changes to longer wavelengths 
are called bathochromic shifts and changes to shorter wavelengths 
are called hypsochromic shifts. An increase in intensity of 
a band is called a hyperchromic effect, while a decrease is 
called a hypochromic effect. The structural character and the 
position of absorption bands depend on the nature of the solvent 
also
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I. Nature of current.
The polarographic limiting current can be controlled by 
different rate limiting processes 1 e. diffusion, catalytic, 
kinetic and adsorption process [62]
(a) Diffusion current
Diffusion current is limited by the rate of diffusion 
of the electroactive species to the electrode (Fig. 1)
Ficks First Law may be written as
B. Polarography.
ndc
Flux = -°a3T (8 )
and Ficks Second Law as
dc = o d^c (9)
dt dx2
The flux may be defined as the quantity of the diffusing
substance which crosses any plane paralell to the electrode surface,
D is the diffusion coefficient and d£ the concentration gradient,
dx
where x is the distance from the electrode surface
The current flowing can then be expressed through
l = nFA(flux)x=0 (10)
•<-($■*■ - _x
Nernst Diffusion Layer “ Distance from Electrode
0 + ne" j  R
cr = concentration of reduced species 
cb
o = bulk concentration of the oxidised species
Fig 1 Nernst Diffusion Layer
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where n is the number of electrons used for reduction, F the
faraday constant (96,446 coulombs) and A the area of the electrode
2
(cm ). Substitution of ( 8 ) into (10) yields,
l = nFAD (11) ,
This leads to,
dc\ = (12)
dx) (TlDt)*
where is the bulk concentration and t the drop time in seconds
Combining equations (11) and (12) yields
i = nFD*Cb (13)
t  r
(ntr
and hence
i = 708.1nD*Cbi i M  (14)
Integration of equation (14) over the drop life gives the 
total number of microcoulombs per drop Dividing by the drop 
life gives the average diffusion current li^).
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’d - 1/t/o iTdt = 607nD*Cbm2/3t1/6 (15)
the Ilkovic equation [63]
(b) Kinetic Currents.
There are many cases where the height of a wave is 
partly o^ wholly determined by the rate of a chemical reaction 
that produces an electroactive substance in a thin layer of 
solution around the mercury drop These waves are called kinetic 
waves.
0 (16)
kb
K = M  (17)
[Y]
where Y and 0 are two interconvertible species reducible at 
different potentials»and k^ and kb the forward and reverse 
rate constants respectively*
When,
0 + ne’ R
The height of the wave will therefore depend on both the 
thermodynamic and kinetic constants for the conversion of Y 
to 0. For a kinetic current it can be shown that
ik = 4 9 3 n D * m V ( k f/kb*)CY (18)
for Y or 0.
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—  Because i^ is independant of m^t3 it can be shown that
l. is independant of h2 (where h is tne corrected height 
k corr corr 3
of the mercury column) and this is used to identify a kinetic
from a diffusion controlled wave.
(c) Catalytic currents
Catalytic currents can arise from a mechanism such as 
0 + ne' R
kf
R + Z Î 0
i.e. compound Z, while not contributing directly to the current,
influences it by combining with the product R to regenerate
0 at the electrode surface. Quantitative results are often 
difficult to obtain for catalytic waves because of the very
nature of the catalytic process. Catalytic currents are also
difficult to identify since they exhibit various types of i^
n ~
versus h dépendances. They can be independent of h or h2
even decrease with respect to h. Only if they decrease with
respect to h can they be classified as catalytic currents
They are also highly dependent on the pH and on concentration
of the electroactive species in solution, and usually a combination
of factors is necessary for their identification [64].
(d) Adsorption Waves.
An absorption wave may be observed if either the 
electroactive species or the product of the electrode reaction 
is adsorbed onto the surface of the drop. Suppose that the 
product of
2 1
is adsorbed. Its activity is lower in the adsorbed state than 
in solution. At low concentrations of 0,all the 0 reaching the 
surface is reduced to Racjs * On increasing the concentration 
of 0 , a point is reached where the drop surface will be completely 
covered by Rads and therefore 0 Rso-|ut-ion Wl1  ^ take Place> 
but at a more negative potential. So the concentration dependence 
can be used to identify adsorption waves,as can the fact that 
l^ varies with ^ c o r r  and not with h£Qrras with a diffusion 
controlled process.
II. Study of the Electrode Process
This involves (i) the determination of the number of electrons
(n) involved in and (n)an investigation into the various rate
processes which make up the electrode process as a whole.
With regard to (i) a rough estimate of n can be 
made by substitution of 0 into the Ilkovic equation.
Concerning (n) it is first necessary to show whether 
the process is reversible or irreversible and for most 
organic species the latter applies This can be indicated
from changes in the half wave potential E^ with both drop time
(becomes more positive) and concentration
In the case of a totally irreversible wave
a potential a the transfer coefficient and n^ the number
of electrons involved in the rate determining step A plot of
En«r versus log i will yield a straight line from which n 
DME \ 
can be calculated.The number of protons (p) which participate
in the rate determining step can then be calculated from
dEi -0.05915 (19a)
d(pH) ana
Deviations from linearality can occur if more than one 
process is in operation at the DME[64].
III. Effect of pH on the electrode processes.
In most organic reductions, protons are involved inthe overall 
electrode process, ^ ( p )9 1cj and the wave shape are thus pH 
dependent. The rate of the chemical reactions occurring both
at the electrode surface and in the bulk of solution are influenced
t
by hydrogen ion concentration hence pH, this is reviewed by 
Zuman[97] Ex and i^ thus vary with pH in the following ways
(i) E, and i indepenaent of pH 
2 d
( n )  Ex pH dependent, l A pH independent.2 U
(m  )Both E^ and i^ pH dependent
In the case of (i) species in the bulk of solution diffuse 
to the electrode surface where electron transfer takes place 
prior to proton addition
In the case of (n) a prior protonation step occurs in solution
where 1 is the current on the rising portion of the wave at
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that both acidic and basic forms diffuse to the electrode surface
at the same rate and that at least one form is electroactive
In the case o f ( m ) f r o m  plots of Ex v s  pH it can be determined
2
whether a multi stage reduction is occuring or not and which 
of the stages is rate-determining.
IV Theory of Differential Pulse Polarography (DPP)
The introduction of DPP after the 1950's by Barker came 
about because DC polarography was not a sensitive enough method 
of analysis High capacitive currents caused this insensitivity.
If the capacitive current (i ) could be decreased then a moreL
sensitive method of polarography would exist. It can be shown that 
1 decays exponentially according to the equation
V
¿ E i - t / R C . )
'c ■ T  <20*'
where AE is the pulse amplitude (mV) and R is the uncompensated 
resistance of the cell, t the time following application of pulse 
and C^ -j is the double layer capacitance.
To provide a theoretical treatment of DPP at the Hg electrode 
for a reversible electrode process,-the following assumptions 
must be made (a) It is assumed that the drop grows instantaneously
(b) It is assumed that the Cottrell equation can be applied.
The equation for the i-E curve for a reversible system may be 
written
EnMF ~ E^ + 2 303 Rt Ioq i*“i (20b)
2 nF - 4 —
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^  = nFCA
NJ
(21)
ntm
If (x) is differentiated and the Cottrell equation substituted 
for the limiting diffusion controlled current the expression
Ai n2F2AC(-AE) 
RT
\l
D_
nt
(2 2)
m(1 + P)'
is obtained where i is the differential pulse current and DE 
is the pulse amplitude
A solution valid for all values lfAE gives
Ai = nFA C D1 pAq2 -  Pa
cj2+|
m A ' A  ' Ant a + P. j^p.+p,,^
(23)
where PA = exp nF [E1+E2 -E^] 
RT 2
(24)
o  = exp nF [E7-E1] 
RT 2
(25)
E^ - E^  = AE, the pulse amplitude
E^ is the potential at which the current 1 is measured
after the application of the pulse. E^ is the potential at 
■Tfhich the current 1 is measured in the absence of the pulse,
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E is negative for reduction. = 1 when 1 is a maximum so 
that the expression or maximum/current (Ai) max is given by
If -AE is smaller than RT, this equation simplifies to 
2 nF
the small amplitude case
where -AE/2 becomes very large with respect to RT/nF, (a-1)/
(a+1) approaches unity and (A i ' 1S simply the Cottrell 
expression.
( In the DPP mode small amplitude pulses (10-100 mV) of ca 
60 ms duration are superimposed on a conventional DC ramp voltage 
and applied to the dropping Hg electrode near the end of the 
drop lifetime The current output is sampled at two time intervals 
immediately on the ramp prior to the imposition of the pulse 
and then again at the end of the pulse (after 40 ms) when the 
capacitive current has decayed It is the difference in these 
two currents that is displayed. As the greatest increase in 
current for a given applied potential increment will occur at 
the half wave potential the l - E curve in DPP will have a peak 
shape
The theoretical relationship between peak current (ip) 
and pulse modulation amplitude (AE) has been developed
(A-I ) MAX = nFAC £ z l (26)
(Ai )m a x = (n2 + F2/4RT) AC( AE) D/ntm (27)
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[97]. The maximum peak current when E <  RT
nF
is directly proportional to both the concentration of the 
electroactive species and AE For a differential pulse polarogram 
with very small values of AE, the peak current potential Ep , 
coinsides with the half wave potential E^. With larger values 
of modulation amplitude, however the E^ is no longer coincident 
with Ex and is given by
Ep = E4 - AE/2 (28)
Consequently it is clear that the maximum sensitivity in
DPP is obtainable for large values of AE. Increases in AE,
however also result in increased peak broadening with consequent
loss of resolution Their definition only apply to “reversible
system”. For irreversible systems i is generally lower and
P
peak widths broader than predicted for reversible systems.,
At low concentrations of electroactive substance DPP is 
sliqhtly more sensitive than normal pulse polarography, (NPP) 
due to a more favourable signal to noise ratio and better 
resolution of t.ie current applied potential curves.
C Cyclic Voltammetry
Cyclic voltammetry (CV) has the capability for observing 
the redox behaviour of an analyte over a wide range of potential 
Cyclic voltammetry consists of cycling the potential of an electrode 
which is immersed in an unstirred solution and measuring the 
resulting current The potential of the working electrode is
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controlled versus a reference electrode The excitation signal 
for CV is a linear potential scan with a triangular wave form 
as shown in Fig 2 . This excitation signal causes the potential 
first to scan negatively from Einitiaj to Efinai at which point 
the scan direction is reversed, causing a positive scan back 
to the orginal potential The scan rate can be varied 
as desired Singleor multiple cycles may be undertaken A 
cyclic voltammogram is obtained by measuring a current at a working 
electrode during the potential scan. The cyclic voltammogram 
is characterised by several important parameters, the cathodic 
(E ), anodic (E ) peak potentials, the cathodic ( L c), anodicr ^ r r  ^
(i J  peak currents, the cathodic half-peak potential (Ep/2) pa
and the half wave potential (E^) (Fig 3.)
2
£ 1 is similar to E already defined in the polarographic2 r
theory outlined The current depends on both the
movement of the electroactive material to the surface 
and on the electron transfer reaction The electron transfer 
rate constant for a reduction process is a function of potential 
and can be described theoretically as.
kf = k°exP (^n£. (E-E°-)) (29)
RT
where k° is the standard heterogenous electron transfer rate 
constant, n the number of electrons transferred per molecule,
F the faraday constant, R the universal gas constant, T the 
Kelvin temperature,E° the formal reduction potential, a the
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Fig. 2 Typical excitation signal for Cyclic Voltammetry
Fig 3 Typical Cyclic Voltammogram
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transfer coefficient. The electron transfer rate constant for 
the rate constant for the reverse process is similarly controlled 
by the applied potential and denoted by
kr = k°exp((1-«)nF) (E°-E°') (30)
If a reaction is reversible, then the separation in the 
peak potentials (AEp), will be close to 59/n mV This relationship 
can be used to evaluate n . By reversible is meant that the 
reaction is fast enough to maintain the concentrations of the 
oxidised and reduced forms in equilibrium with each other at 
the electrode surface The equilibrium ratio is determined 
by the Nernst Equation, where x is the distance from the 
electrode surface
E°* -RT
IR1) (31)— 1n ( 
nF "[Opx = 0
where 0 is the oxidised form and R is the reduced form At 
slow scan rates most systems appear reversible, reversibility 
then depends on the stress that is applied to the system. Redox 
systems whose peaks shift further apart with increasing scan 
rate are known as quasi-reversible As the peaks get more 
widely separated the system is said to get more irreversible 
Irreversible reactions may be defined as reactions that yield 
products that cannot be recycled electrochemically to give back
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reactants, and usually yield no return peak
A characteristic of reversible systems is their dependence 
on their peak height and the square root of the scan rate 
The peak current for a quasi-reversible system is not proportional 
to the square root of the scan rate except when the peaks are 
so widely separated that the system is more appropriately described 
as totally irreversible The real forte of CV is the analysis 
of homogenous chemical reactions that are coupled to the electron 
transfer process Determination of coupled chemical reactions 
is often based on the relative heights of the anodic and cathodic 
peaks.
D. High Performance Liquid Chromatography.
A chromatogram results from separating one sample component 
from another Resolution describes the degree of magnitude 
of separation [68] Resolution may be represented by,
i(w1 + w2)
where and \l^ are retention volumes of hypothetical samples 
1 and 2, respectively and the base width of the peak (Fig. 4)
A peak is usually identified using some measure of retention(Fig.5) 
Often retention time is used, measuring from the time of injection 
to the point where the peak apex appears A more universal 
term frequently used to identify a peak is the capacity factor
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V=0
Fig 4 Illustration of the Resolution of a Chromatogram
Fig 5 Relating the volume of the Mobile Phase to the Flow Rate 
and Retention Time
/
50
Fig 6 Void Volume is often measured from the Injection Point 
to the Solvent Front, simplifing the estimation of
i
k values
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k*. The capacity factor of a given component is defined as 
follows,
k' = vi - (33)
where and VQ are measured in terms of the same units VQ 
is called the void volume and is a measure of retention for
an unretained component The void volume of a system (in terms
of volume) is a measure of system volume from the injection point to
the detector (Fig 6).
The elution time is a function of the mobile phase velocity 
and the volume of the mobile phase required to elute a component 
from the column, the retention volume (V^) is given by
VR = FxtR (34)
where F is the volume flow rate of the mobile phase The volume 
of the column available to the mobile phase is
\  = Fxtm (35)
Capacity factor (k‘) values reveal where bands elute relative 
to the void volume These values are unaffected by such variables 
as flow rate and column dimensions A selectivity factor denoted 
by a reveals where two peaks elute relative to one another
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The selectivity factor is defined for two bands only and is 
equal to the ratio of their k' values
(<2* _ Vp - Vq
= - 1 ---- 9. (36)
ki' V1 - V0
The k' values tell us where bands elute relative to the 
void volumes and a values tell us where bands elute relative 
to each other.
The theoretical plate number (N) of a system describes 
the deviation of a band around the centre. The theoretical 
plate count can be represented by
N = (V}2 (37)
where V is measured in units of volume, time or distance and 
2
s the band variance in terms of the same units,
s = W (38)
J
where U is the peak width measured on the extrapolated 
4
baseline Plate count is often used as a measure of column 
performance.
The expression used to calculate column length (L) to plate 
count (N) is.
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k  (39)
N
Where H is the height extrapolated to the theoretical plate 
Taking equations (31), (32) and (33) into consideration with 
the following equation,
M - 16 V? 2
N ' (— ) (40)
w
the result is,
Rs = i ( — ) N (—  ) (41)
a k'+1
This expression shows the expected relationship of a, k *, 
and N to the resolution (R$), [69,70].
EXPERIMENTAL
Ultraviolet spectra were recorded using a Shimadzu Recording 
Spectrophotometer UV-240 (P/N 204-58000) with matching 1 cm 
quartz cells Readings of pH were made on a Philips digital 
pH meter PW 9410 with an Orion saturated calomel electrode (S C E ) 
91-05 and a temperature compensating device The pH meter was 
calibrated before use with standardised buffer solutions of pH 4, 
pH 7 and pH 9
Polarographic curves in the differential pulse mode were 
obtained using an EG & G Princeton Applied Research (PAR) Model 
174A polarographic analyser and an EG & G Par Model Re 0074 
X-Y recorder in conjunction with an EG & G PAR Model 303 SMDE 
containing a three-electrode cell system. The working electrode 
was a dropping mercury electrode (DME), the counter electrode 
a platinum wire and the reference electrode a saturated 
calomel electrode. The cyclic voltammetric experiments were 
performed using the same equipment as that used in obtaining 
the polarographic waves, in association with an EG & G PAR Model 174 
Universal Programmer (Fig.7). The working electrode used was either 
a glassy carbon electrode or the DME
Isocratic chromatograms were obtained with a Waters M- 
solvent delivery system and injector Model U6K in conjunction 
with a Waters Model 450 variable wavelength liquid chromatographic 
absorbance detector (Fig 8) The area under the peaks was 
measured with a Hewlett Packard Reporting Integrator Model 3390a.
Gradient liquid chromatography was performed with a Waters
A. Apparatus and Materials
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Fig 7 Flow diagram for Cyclic Voltammetric Instrumentation
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Fig 8 Flow diagram for Liquid Chromatographic System
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Model 6000A solvent delivery system (dual) with solvent programmer
in conjunction with a constant wavelength ultraviolet detector
operated at X=280nm.
The chromatographic system (solvent delivery system and
detector) was allowed to equilibnate for one to one and a half
hours before any samples were injected Steel columns and Radial
pak columns were used throughout the separations ( yBondpak
g (8MBC^g ,10u), yBondpak -NH^ ,(8MBNH2 ,10p) and yBondpak -phenyl
(8MBPh ,10u) ,all manufactured by Waters) A radial compression
system (Z-Module) was used for some separations.
Samples of oxytetracyclme hydrochloride were obtained
from the Pfizer company, USA. Stock solutions of oxytetracyclme
_2
hydrochloride '(10 M) wre prepared in Analar merhanol and stored in
the_dark. The metals used were all of Analar grade except chromium and
aluminium,and stock solutions of metals were made up in water
which was distilled before being passed through a Waters Millipore
system to remove metals and organic impurities. Iron(II) was
not made up in water like the other metals, instead it was made
up in 0 1M sulphuric acid to prevent its oxidation to the +3
_2
state. The metal stock solutions were also of 10 M and stored 
in the dark The stock solutions of antibiotic and metals were 
diluted when necessary using Oxford micropipettes, range 0-200 y 1 
for analysis
All chemicals used to make up the buffer systems were of 
analytical grade Four buffer systems were used throughout 
this research A stock solution of Britton-Robinson (BR)_ buffer.  __
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solution (pH - 1 8) composed of a mixture of boric Acid, ortho­
phosphor ic acid and glacial acetic acid, all 0 04M was prepared. 
Addition of 0 2M sodium hydroxide (NaOH) gave a range of buffers
from 1.8-12 0 for the determination of pK values of the antibiotic.
a
A Walpole acetate (WA) buffer solution was prepared from 0 1M 
acetic acid and 0.1M sodium acetate, its pH range being 3 5-5*6 
A study was done at pH 4 using this buffer system. Another 
study was undertaken in a Michael is Phosphate (MP) buffer system 
at pH 7.2, this was prepared from stock solutions of 0 067M 
potassium dihydrogen orthophosphate and 0 067M disodium hydrogen 
phosphate mixed in appropriate amounts to produce 
the desired pH
An 0.1M potassium chloride salt solution,pH 5.4,was also 
used as an electrolyte to study the metal complexes of the 
antibiotic. (Optimum results were found using this electrolyte )
Since the average concentration of the analytes throughout
-5
this research was 5 x 10 M, great care had to be taken with 
regard to contamination of the analytes. All glassware was 
chromic acid washed. All glassware after use was steepped 
overnight in a 2M nitric acid solution made by diluting 128 cm3 
of concentrated nitric acid with 872 cm^ of water, this nitric 
acid was changed regularly and the glassware washed in 
soapy water and rinsed a few times with Millipore water (described 
earlier) and air dryed.
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B. Techniques
I Ultraviolet Spectral Investigations 
In ascertaining the ultraviolet spectral behaviour of
oxytetracycline hydrochloride to determine its pKa values, 50 yl of
p 3
a 10 M stock solution was taken and diluted to 10 cm with
the appropiate volume of buffer, in this case the buffer used
was the Britton-Robinson (BR) universal buffer (pH 2-12), 0 2 M
sodium hydroxide was added dropwise to increase the pH of the
i
buffer when necessary The pH of the buffer system was increased
in 0 5 pH increments and UV spectra of oxytetracycline hydrochloride
obtained. At the begimng of each UV investigation, the lamp(s) in the
spectrophotometer were allowed to equilibriate for 15 minutes,
before placing appropriate solutions (test and blank) in both
the scanning and reference beams and scanning between 200 nm
and 500 nm The values of the absorbance (A) at a specific
wavelength (x) were then noted and plots of absorbance versus
pH extrapolated, these plots yielded sigmoidal curves of which
pK^ values could be read off directly (Fig. 10).
In ascertaining the UV spectral behaviour of oxytetracycllne-
metal complexes to determine possible binding sites of the
_2
antibiotic to metals 50 y 1 of a 10 M stock solution of
3
oxytetracycline ( m  methanol) was taken and pipetted into a 10cm 
volumetric flask. An appropriate amount of metal was added depending 
on what type of complex was to be formed, i.e a 1 1 complex 
involved taking 50 yl of a 10 M stock solution of metal and 
adding it to an equimolar of antibiotic in a 10 cm3 volumetric
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flask and making it up to the mark with the appropriate buffer.
The amount of metal ions added to the antibiotic was increased in 
50 u 1 increments making 1 1, 1 2, 1 3, 1 4, 1 5 ratios as 
required The spectra obtained were then examined for any 
evidence of the complexation between the antibiotic and metals
II Polarographic Investigations.
In ascertaining the differential pulse polarograms (DPP)
_2
of oxytetracycline ,50 \ i 1 of a 10 M stock solution (in methanol) 
was diluted to 10 cm with the appropriate buffer or electrolyte 
and de-aerated using a steady stream of oxygen free nitrogen 
A scrubbing system based on a vanadous chloride scrubbing solution 
(Fig. 9), in conjunction with a saturated EDTA solution and 
finally Millipore water was used. This system ensured an oxygen 
and metal free nitrogen. Solutions being analysed were deaerated 
for four minutes This gas being passed over the solution 
and the i-E curves (polarograms) recorded in the DPP mode between 
-0 1V and -1.9V depending on the buffer used, the buffer acting 
as an electrolyte The method used to determine Ep and ip 
from these polarograms is shown in Fig 11. A scan rate of 
2 mV/sec., a modulation amplitude of 25 mA, a sensitivity current 
range of 10 yA, and a drop time of one second was used. A 
similar technique was used in obtaining polarograms of the 
complexes of oxytetracycline hydrochloride with various metals
III Cyclic Voltammetric Investigations.
In ascertaining the cyclic voltammograms of oxytetracycline 
and its metal complexes,50 yl of a 10 M stock solution (in
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Fig 9 Scrubbing System used in Polarographie and Cyclic 
Voltammetric Investigations
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Fig. 10 Plot of Absorbance vs pH to determine pKa values
Fig. 11 Method for Extrapolation of Polarographie Data
methanol)was diluted to 10cm3 with electrolyte/buffer and placed
in the cell and de-aerated using a steady stream of oxygen-free
nitrogen The solutions to be analysed were de-aerated for four minutes.
The cyclic voltammograms were obtained between -0 8 and 1 9V
The scan rate was varied between 20 mV/sec and 100 mV/sec, a
current range of 10yA was used Single cycles and repeated
cycles were recorded. The hanging Hg drop was replaced
each time new cycles were undertaken by dispensing of the old
drop. Triton X -100 was used in the cyclic voltammetric
experiments as a maximum suppressor.
IV Chromatographic Investigations
In ascertaining the chromatographic behaviour of 
oxytetracycline hydrochloride 50 ul Of a 10‘2M stock solution 
was made up to 10 cm in methanol, this solution was then filtered 
using a Sartorius 0 2 ym disposable filter and 20 yl of it injected 
onto the column. The solvents (mobile phase) used throughout 
the chromatographic investigations were water / methanol mixtures 
and water/acetomtri1e mixtures Investigations were undertaken 
in 100 0 methanol water down to 50 50 methanol water in 
10% increments and similarly for the water/acetonitrile mobile 
phase These solvents were filtered under vacuum using a 0 45 ym 
Sartorius disposable filter and degassed for a period of time 
(depending on the polarity of the sol vent)using a sonic bath.Pure 
water for example,was degassed for 30 minutes. The chromatographic 
system was allowed to equilibriate for one to one and a half 
hours before being subject to any sample injection.
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The metal complexes of the antibiotic were made up as 
previously described i e to obtain a one to one (1 1) ratio 
equimolar solutions of metal and antibiotic were added together 
in a volumetric flask and diluted to the mark with methanol 
and filtered etc. before injection Fresh samples of oxytetracyclme 
and its metal complexes were made up each time before analysis, 
the analysis of the antibiotic and the metal complex of the 
antibiotic was done within 15 minutes of its preparation
RESULTS AND DISCUSSION
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A. Ultraviolet spectral studies on Oxytetracycline and its 
metal complexes.
I. Ultraviolet spectra in aqueous solution, pKfl values 
Oxytetracycline hydrochloride exhibited four distinct changes 
in ultraviolet spectral behaviour in aqueous solution pH 1-12^Fia 13) 
The spectral characteristics of each species and the pKa values 
as determined from plots of absorbance vs. pH at selected 
wavelengths (Fig 12a and 12b) are collected in Table 4 These spectral 
results provided evidence for the existence of a fourth pK a
(10 3) which is in qualitative agreement with both the value
determined for the tetracycline methioide derivative [71] and
the pK value assigned to the deprotonation of the 12-OH group 
a
in 10-benzenesulfonyloxytetracyclinomtrile (IV), [72] The 
pK9 and pK~ VBftres were found to be 3.3, 7.5 and 9.7 respectivelyL 0
Da Silva et ai.[73] have determined pK^, pK2 and pK^ to be 3 26,
7 25 and 8.73 respectively,and Albert [17] has determined pK^, 
pK2 and pK3 to be 3.27, 7 32 and 9 11 respectively, these values 
are in good qualitative agreement with the values determined 
here
It has been shown [72] that for öxytetracycline hydrochloride that 
the BCD chromophore is alone responsible for ultraviolet absorbtion 
at wavelengths > 330 nm (\|) This would appear to be consistent 
with the aromatic nature of the D ring and hence the 
intense tt tt* transitions evident from Table 4. The ultraviolet 
absorntion at wavelengths < 330 nm is mainly due to the A 
chromophore U 2 ), although it is also partially due to the BCD
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Fig 12a Plot of absorbance vs pH for oxytetracycline hydrochloride 
in Britton Robinson buffer to determine pK^
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Fig. 12b Plot of absorbance vs pH for oxytetracycline hydrochloride 
in Britton Robinson buffer to determine pK2, pK^ and pK^
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Fig. 13 Ultraviolet Spectra of Oxytetracyclme hydrochloride
in Britton Robinson Buffer, pH 2.0 (---- ), pH 5 0
(----), pH 7 0 (-----), pH 9 5 ( • ) and pH 11 5 (- • -)
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Chromophore [72]
The pK values of Oxytetracycline hydrochloride were assigned 
a
on the same grounds as Conover [10] and Smyth e t  ai [4], the 
former authors indicating at what sites pK^ and p«2 occurred and the 
latter indicating at what sites pK^ and pK^ occurred in a similar 
antibiotic
Since the functional groups of tetracycline hydrochloride
and Oxytetracycline hydrochloride involved in the acid-base
equilibria are identical,the explanation and assigments of specific
functional groups to particular pK values of Oxytetracyclinea
hydrochloride are equivalent to that of tetracycline hydrochloride;
pK^ being assigned to the -OH group attached to C^, pK^ to the
ammo function at C^, pK^ to the -OH group attached to C^ and
pK^ to the -OH group attached to C ^  (Fig. 14)
The most important feature of this study was the evidence
of a fourth pK value for Oxytetracycline hydrochloride. Smyth 
a
et ai. [4] have reported a fourth pK value for tetracyclinea
hydrochloride previously Since irreversible decomposition 
(change in colour of solution) is detectable at pH > 12, suggesting 
either skeletal rearrangement or ring opening of the antibiotic 
in strong alkaline media, the study is time-dependent and has
to be undergone as quickly as possible
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Fig. 14 The Acid - Base Equilibria of Oxytetracycl m e  hydrochloride 
as visualised by Ultraviolet Spectrophotometry
"Species X max/nm
pK values (wavelength
a
at which determined/nm)
h 4a+ 215, 267, 317sA., 353
pK1 = 3.3 ± 0.1 (300) 
pK, = 7 5 + 0 1 (300)
H3A 213, 249sii. ,273, 359
h 2a
o
211, 227sh , 248, 270, 364 L
pK, = 9.7 + 0 1 (330)
HA
0
211, 248, 269, 374 $
pK- = 10.3 + 0 1 (325)
A3 212, 248, 268, 280sh , 374,
sh = shoulder.
TABLE 4.
Spectral characteristics and pK^ values determined for 
oxytetracyclme hydrochloride
II. Ultraviolet spectra in aqueous solution, metal 
complexation
Ultraviolet spectra of oxytetracyclme hydrochloride 
were obtained in different buffer solutions at different pH's.
The spectral characteristics of these are listed in Table 5. 
Ultraviolet spectra were also obtained for oxytetracyclme-metal 
complexes in different buffer solutions at different pH's (Fig 17- 22 
Their spectral characteristics are listed in Table 6
When a solution of Cu(II) ion (5 x 10~^M) was added 
to an equimolar solution of oxytetracyclme hydrochloride, a 
green colour was observed When this solution was diluted 
appropriately with buffer and subjected to ultraviolet investigation 
it was found that (absorbance due to the BCD chromophore,
Scharr et aiJ[74] had undergone a bathochromic shift (Fig. 17). When 
Cu(II) ion solution was increased to twice the concentration
71
of that of the antibiotic a further bathochromic shift occurred
to X„ and Xn also underwent a bathochromic shift When the buffer 1 2
used was 0.1M potassium chloride solution the first shift a Ffected 
X^by 12 nm and X^ by 2nm Since Scharr et a i [74] concluded that at 
X>330nm U.V. absorbance was due soley to the BCD chromophore of 
the antibiotic it is reasonable to assume that chelation of 
the Cu(II) ion is occurring at this site. The manner in which 
it is mostly probably chelating is indicated in Fig 15.» Of
the structures indicated structure (Vila) would be the most
probable because of the ease of loss of the proton which is
resonating between O^q and 0 ^  and retention of the benzene ring in
ring D.
Buffer
BCD Chromophore A Chromophore 
X^/nm X^/nm
Walpole Acetate pH 4 0 353 275
0 1M Potassium Chloride pH 5.4 353 275
Britton Robinson pH 7.0 358 274
Michaelis Phosphate pH 7 17 358 274
TABLE 5.
Spectral characteristics of Oxytetracycline hydrochloride in 
various buffer solutions
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CH3 OH OH H n[CH3)2
(VII)
XONH2
CH3 pH OH HN[CH3)2 
JOH
(V ila)
> s r - '
Fig.15. Possible chelating sites of the fu(II) ion to 
Oxytetracycline hydrochloride (BCD chromophore)
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CH3 OH OH HN[CH3)2
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0
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CHq OH OH Hn(CH3)2
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CH3 OH OH Hn(CH3) 2
NÌÌH2
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Fig. 16. Possible chelating sites of the Cu(II) ion to 
Oxytetracycline hydrochloride (A chromophore).
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Fig. 17 Ultraviolet Spectra of Oxytetracyclme hydrochloride 
(OTC), (---- ), OTCsCu(II) 1:1 (----), OTC Cu(II) 1 2
(----- ,) and OTC Cu(II) 1:3 (--------) in 0.1M KC1
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Oxytetr acyc 1 m e . M (11)/M (111) Stoichiometry X^nm, X2/nm Buffer
OTC M(II)/M(III)
OTC Cu(II) 1 1 359 275 0.1M KCl
OTC Cu(II) 1.2 365 277 0.1M KCl
OTC.Cu(II) 1 3 365 279 0.1M KCl
OTC Fe(III) 1 1 353 265 0.1M KCl
OTC.Fe(III) 1 2 345 265 0.1M KCl
OTC Ni(II) 1.1 368 271 Michaelis 
Phosphate 
Buffer
OTC Ni(II)
1 I L 1 ä'3 1 ~ S
1 2 372 270 Michaelis
Phosphate
Buffer
OTC Co(11) 1 1 361 271 Michaelis
Phosphate
Buffer
OTC Co(II) 1-2 363 269 Michaelis
Phosphate
Buffer
OTC Co(II) 1 4 366 269 Michaelis
Phosphate
Buffer
OTC Fe(II) 1 1 353 274 0.1M KCl
OTC Fe(II) 1-2 353 270 0.1M KCl
TABLE 6.
Spectral characteristics of oxytetracycline metal complexes in / 
various buffer systems.
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Fig 18a Ultraviolet Spectra of Oxytetracycline hydrochloride 
(OTC), (---- ), OTC Fe(III) 1 1 (---- ), OTC Fe(III) 1 2
only (---- ) in 0.1M KC1
IAs the concentration of the Cu(II) ion is further increased 
X2 undergoes a further shift of 2 nm, and when it is increased 
further no other shifts occur to either X^  or X 2
In conclusion,chelation of the Cu(II) ion would first appear 
to occur at the BCD chromophore and when this site is saturated, 
chelation of the Cu(II) ion would then occur at the A chromophore 
It would appear that the BCD chromophore has more of an affinity
for the Cu(II) ion than does the A chromophore
-5
When a 5 x 10 M solution of an Fe(III)ion was added to 
ann equimolar solution of o<ytetracycline hydrochloride,a brown 
colour was observed (complex formation). When their solutions 
were diluted appropriately with a 0.1M KC1 solution and investigated 
using ultraviolet spectroscopy dramatic changes in their spectra 
were observed (Fig. 18a and 18b). A strong absorption band 
appeared at 440 nm, X-j broadened considerably, another absorption 
band appeared at 325 nm and a hypsochromic shift occurred 
at x2> this shift was in effect 9 nm This shift indicated 
that the Fe(III) ion was binding to the antibiotic at the A 
chromophore in a manner indicated earlier for the Cu(II) ion 
(Fig. 16) As the concentration of the Fe(III) ion was increased 
to t/nce that of the antibiotic,a hypsochromic shift occurred 
in X-j- This shift indicated binding of the Fe(III) ion to the 
BCD chromophore in a manner indicated earlier for the Cu(II) 
ion (Fig15).
In the case of the Cu(II) ion,binding to the BCD chromophore 
occurred before binding to the A chromophoreJin the case of the 
Fe(III) ion the opposite occurs. It would appear that the Fe(III)
77.
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ion has a greater affinity for the A chromophore than does 
the Cu(II) ion.
When the Ni(II) ion (5 x 10“5 M) was added to an equimolar solution
of oxytetracycline hydrochloride and diluted appropriately with
a 0.1M potassium chloride solution and this solution
was subjected to an ultraviolet investigation, no shifts in
wavelength occured. Even when the concentration of the Ni(II)
ion was increased further no changes in their ultraviolet spectra
-5
occurred. However when an equimolar solution (5 x 10 M) of 
the Ni(II) ion and oxytetracycline hydrochloride were diluted 
appropriately with Michaelis Phosphate buffer and exposed to 
ultraviolet radiation a bathochromic shift occured in of 
10 nm (Fig. 19a and 19b) indicating chelation of the Ni(II) 
ion to the BCD chromophore of the antibiotic. The Ni(II) ion 
would appear to be chelating to the BCD chromophore in a manner 
indicated earlier for the Cu(II) ion (Fig. 15).
As the concentration of the Ni(II) is increased to twice 
that of the antibiotic, a further shift occured in and a 
hypsochromic shift occurred i n A 2 of 3 nm indicating that the 
metal might be binding to the A chromophore in a manner indicated 
earlier for the Cu(II) ion (Fig 16). As the concentration 
of the Ni(II) ion is increased further no more shifts in the 
ultraviolet spectra of the antibiotic metal complexes were observed. 
It would also appearsas in the case of the Cu(II) ion that the 
Ni(II) ion binds to the BCD chromophore in preference to the 
A chromophore; binding to the A chromophore only occuring when 
the BCD chromophore is saturated.
200 WAVELENGTH(X)/nm 500
Fig. 19a Ultraviolet Spectra of Oxytetracycline hydrochloride (OTC)
(---- ), OTC Ni(II) 1 1 'OTC Ni(II) 1 2 (-•-•),
Fig. 19b Ultraviolet Spectra of OTC Ni(II) 1:4 (---- ),
and OTC.Ni(II) 1.5 (---- ) in Michaelis Phosphate Buffer
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Fig 20a Ultraviolet spectra of Oxytetracycline hydrochloride (OTC) 
(---- ), OTC Co(II) 1 1 (---- ), OTC Co(II) 1 2 (---- ),
Fig. 20b Ultraviolet Spectra of OTC Co(II) 1 4 (---- ), and
OTC Co(II) 1*5 (---- ) in Michaelis Phosphate Buffer
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An ultraviolet spectral study of Co(II)-Oxytetracycline complexes 
was conducted in a 0.1M potassium chloride solution, a Walpole 
Acetate buffer solution and a Michaelis Phosphate buffer solution. 
Using the 0.1M potassium chloride solution and the Walpole Acetate 
buffer solution no substantial changes in wavelength were 
observed.
Dramatic changes in the UV spectra of the Co(II)-oxytetracycline
complexes were observed (Fig. 20a and 20b) in a Michaelis phosphate
-5
buffer solution. An equimolar (5 x 10 M) of the Co(II) ion and 
Oxytetracycline caused a bathochromic shift in by 3 nm and 
a hypsochromic shift in by 3nm. As the concentration of the 
Co(11) ion is increased ,the bathochromic shift occuring at 
continued as does the hypsochromic shift at until the 
concentration of the Co(11) ion is four times that of the antibiotic. 
Because both and X^ are affected by the addition of the Co(II) 
ion it cannot be said to what sites the Co(II) has a preference 
for,as in the case of the other metals studied. The Co(II) 
ion is more than likely binding to either the BCD Chromophore 
or the A chromophore but which site it binds to first remains 
unknown.
An ultraviolet spectral study in a Walpole Acetate buffer 
and a Michaelis Phosphate buffer of Oxytetracycline hydrochloride- 
Fe(II) metal complexes gave no conclusive results. However 
a study conducted in a 0.1M potassium chloride gave some conclusive 
results.
An equimolar (5 x 10~^M) solution of the Fe(II) ion and 
Oxytetracycline hydrochloride when subjected to an ultraviolet
200 WAVELENGTH(X)/nm 500
Fig. 21a Ultraviolet Spectra of Oxytetracycline hydrochloride (OTC)
(---- ), OTC Fe(II) 1 1 (---- ), OTC Fe(II) 1 2 (--•)
Fe(II) 1 5 (---- ), OTC Fe(II) 1 6 OTC Fe(II)
1 7 (----- ) in 0.1M KC1
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spectral investigation (Fig. 21a and 22b) showed a hypsochrotnic 
shift in by 4 nm. This shift would appear to be due to 
the binding of the Fe(II) ion to the A chromophore of the antibiotic 
in a manner described earlier for the Cu(II) ion (Fig 16)
As the concentration of the Fe(II) ion is increased,two shoulders 
begin to appear at 315 nm and 430 nm; these shoulders become 
more pronounced as the concentration of the Fe(II) ion is increased. 
Because no other shift of any type occurs it cannot be stated 
that binding to the BCD chromophore definitely occurs.
Up to this point it would appear that all the metal ions 
in the (II) oxidation state bind to the BCD chromophore*, this 
does not apply in the case of the Fe(II) ion. It would appear 
that the iron ion in the (II) or (III) state has a preference i  
to bind to the A chromophore.
An ultraviolet spectral study of equimolar (5 x 10“5) Mg(II) 
ion and oxytetracycline hydrochloride solutions in Michaelis 
Phosphate buffer revealed a bathochromic shift related to \ y  
This shift implied binding of the Mg(II) ion to the BCD chromophore 
of the antibiotic in a manner described for all other metals (Fl9 15) 
in the (II) state,except Fe(II) (Fig 16). As the concentration 
of the Mg(II) ion was increased no further shifts were observed 
in ultraviolet spectra obtained. No conclusion as to the binding 
of Mg(II) to the A chromophore of the antibiotic can be stated
v
because of the lack of evidence obtained.
An ultraviolet spectral investigation was undertaken in 
a Walpole Acetate buffer, a Michaelis Phosphate buffer and a'
i
0.1M potassium chloride solution of the Zn(II) and Mn(II) ions, 
with oxytetracycline hydrochloride. No shifts in their spectra 
were observed.Therefore it cannot be concluded at what sites 
the metals are binding to the antibiotic.
In conclusion Cu(II), Ni(II), Co(II) and the Mg(II) ion 
tend to bind to oxytetracycline hydrochloride in a similar fashion, 
the Fe(II) and Fe(III) ion bind in a different manner.
B. Polarographic Studies on Oxytetracycline hydrochloride and 
its metal complexes.
I. Polaroqraphyin aqueous solution, pK^ values.
Polarography has been used extensively as an analytical 
method for the analysis of tetracyclines I^8-3b]. Dxytetracyclme 
shows a complicated pattern of waves in acid, neutral and basic 
media and although the current obtained for the first wave (or 
peak) is generally proportional to concentration (thus forming 
the basis of an analytical procedure),there still remains doubt 
as to the site(s) in the molecule that is responsible for the 
electroactivity.
Caplis [8] showed the tetracycline hydrochloride was reduced 
at the keto group in the A ring of the molecule when 
dimethylsulphoxide was employed as a solvent In aqueous solution, 
however,the reduction of these antibiotics depends greatly on 
the availability of protons,and product isolation is hampered 
by the effects of competing side reactions. Caplis [8] showed 
that the total polarographic response for tetracycline hydrochloride 
acid and base media was irreversible and postulated that the
85.
reduction was associated with the second pK value Howevera
Smyth et ai [4] have postulated that the keto group in position 
11 was also involved in the reduction process.
The polarograms obtained in the Britton Robinson buffer 
between pH 2 and pH 12 are illustrated in Fig. 23 and exhibit 
between two and six peaks. At pH 2 and pH 2.5 the peak potentials 
and Ep2 appear, at pH 3.0, however another peak potential 
appears namely Ep  ^because of the high concentration of hydrogen 
ion below pH 3.0 this wave is not visible. At pH 3 0 however 
Ep2 tends to split up into E^, and E^ ,,,' a 'comparisomn height 
of these peaks leaves Ep(j and Ep approximately 5 - 8  times 
greater than the Ep  ^ peaks As the pH is further increased 
Ep2 is split into 3 peaks namely Ep2,, E 2>. and Ep2,M9 at pH
5.0 Ep2 has only split into two peaks namely Ep2, and E^,, and 
remains like this until pH 8 0 is reached when only one Ep  ^
peak appears. Between pH 8 0 and 9.0 it splits into three peaks 
again Ep2, and Ep2„ and E between pH 9.0 and 10.5 Ep2 splits 
into two peaks and at pH 11.0 and greater, only one Ep^ peak 
appears and Ep3 disappears completely.
Plots of Ep v s  pH are illustrated for Ep  ^ and Ep  ^ in Fig.
24. The E ^  v s  pH plot consisted of four linear portions, the 
first change in slope occured at pH 6 5 which is presumed to 
be the pK^ value, a break in the slope due to pK^ is not seen 
because although the equilibrium shown below lies more to the 
right at this pH there is still an excess of protons in the 
vicinity of the antibiotic and it can be reprotonated very easily.
86
\\
i
v
v
1 - o n  - 1 0  1 1
Potential \fe SCE
Fig. 23 Differential Pulse Polarograms of Oxytetracycline 
hydrochloride in a Britton Robinson Buffer pH 2.0
(---- ), pH 4.0 pH 6.0 (-•-), pH 8.0 (•• •)»
pH 10 00 (-----   )
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Fig. 24 Plots of ( E ^  and E ^ )  v s  pH for waves exhibited by Oxytetracycline hydrochloride
arrn<;c thp nH rarmp
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The second change in slope occured at pH 7.7 which is near to
the second pK value of oxytetracycline (6.7) determined by 
a
ultraviolet spectroscopy.
The third change in slope occurred at pH 10.0 and is indicative
of pK^. The slope of the line after pH 10 is zero which implies
that no protons are involved in the electrode process at this
stage. Since this plot of vs pH indicates the second
pK value of oxytetracycline hydrochloride it is reasonable to a
assume that the wave of peak potential Ep1 is responsible for 
the reduction of the A ring in oxytetracycline. This is in 
agreement with Caplis [8] who indicated that for tetracycline 
hydrochloride,at least a portion of the current responsible 
for the first polarographic wave was a function of the protonated 
tertiary amine salt group at This is taken further here 
in that it is postulated that the two possible reduction sites 
in the A ring i.e the carbony groups and their corresponding 
double bonds are being reduced.
Plots of the Ep2 waves proved to be very difficult to 
interpret so are not indicated in Fig. 24, because of the height 
of these waves in comparison with Epl and Ep3* they might be
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Fig. 25 Differential Pulse Polarograms of Oxytetracycline
hydrochloride in 0.1M KC1 (---- ), Michaelis Phosphate
Buffer (----) and Walpole Acetate Buffer (---- )
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considered as adsorption waves. A plot of v s  pH is also
indicated in Fig. 24, and consisted of two linear portions.
The change in slope occurred at pH 8.4 and is probably due
to the third pK value of Oxytetracycline hydrochloride. Neither 
a
of the first two pK, values of Oxytetracycline hydrochloride
a
appear to be associated with this plot and would appear to
show that the electrochemical reduction therefore must not
be occurring in the A ring. Instead another site in the
antibiotic is being reduced and more than likely this site
is the BCD Chromophore. Since pK^ is in close approximation
with the spectroscopic (9.7) and polarographic (8.4) pK values,a
it is presumed that the current involved with Ep  ^ is due to 
the carbonyl moiety or double bonds on the BCD chromophore
In summary then the following conclusion can be drawn 
Peak 1 is due to carbonyl groups and their corresponding double
bond in the A ring, Peak 2 is due to absorption of the antibiotic
onto the surface of the electrode, Peak 3 is due to the reduction 
of the carbonyl group(s) and/or conjugated carbon group(s) 
in the BCD rings.
II. Polarography in aqueous solution, metal complexation.
In a 0 1 M potassium chloride solution significant changes
in the polarographic behaviour of Oxytetracycline hydrochloride 
were recorded in the presence of Cu(II), Ca(II), Fe(III), Ni(II),
Zn(II), Mn(II), Co(II), Al(III) and Mg(II). In the case of :
Cu(II) ions (Fig 26) the height of all the differential pulse 
polarographic peaks was increased in size when the Cu(II) ion cocentration 
increased to 4 x 10~^M (8 times that of the concentration of
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Fig. 26 Differential Pulse Polarograms of Oxytetracycline
hydrochloride (OTC) (---- ), OTC Cu(II) 1.1 (---- ),
OTC-Cu(II) 1-2 ( - -  ), OTC-Cu(II) 1:3 (••••), and 
OTCLCu(II) 1 4 (— ----) in 0 1M KCl
the antibiotic). On addition of an equimolar solution of Cu(II), 
no change in the peak potential of the first wave ( )  occurred. 
However, peaks two and three (Ep2 and ^ 3) changed significantly 
to more positive peak potentials, with a significant increase in the 
height of peak three (Ep^) to match that of peak two (Ep2).
Peak four (Ep4) also moved to more positive potentials and increased 
in height linearly with increasing concentration of Cu(II). Peak 
four might thus be used as an indirect method for the determination 
of the Cu(II) ion. As the concentration of Cu(II) is increased, 
the first peak (Ep )^ also begins to move to more positive potentials. 
From the ultraviolet spectral evidence outlined earlier with regard 
to the binding of Cu(II) to the BCD chromophore of Oxytetracycline 
hydrochloride, it would appear that peaks two, three and four (Ep2* 
Ep^and Ep^) are associated with this BCD chromophore since the 
dramatic polarographic changes occur here initially It is not until 
the concentration of Cu(II) is increased further that the first 
wave (Ep-|) appeared to be affected. This implies that waves two, 
three and four (Ep2, Ep^ and Ep^) are due in part, if not fully, 
to the reduction in the BCD chromophore of Oxytetracycline 
hydrochloride. It would also appear that the BCD chromophore has 
more affinity for Cu(II) than does the A chromophore.
In the presence of Ca(II) ions (Fig 27a and 27b), the height 
of all the differential pulse polarographic peaks increased in size 
when the Ca(II) ion concentration increased to 4 x 10~^M (i.e. ratio 
of OTC Ca(II) was increased to 1*8), except wave three (Ep^) 
when the concentration of Ca(II) and Oxytetracycline were 
equivalent. When an equimolar solution of Ca(II) and Oxytetracycline 
were examined polarographically, no change was
92.
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Fig. 27a Differential Pulse Polarograms Oxytetracycline
hydrochloride (OTC) (---- ), OTC Ca(II) 1 1
OTC Ca(II) 1 2 (-•- ), OTC Ca(II),1 3 (•• •) and
OTC Ca(II) 1 4 ( - ---- ) in 0.1M KCl
A
|1/jA 
l
Fig. 27b Differential Pulse Polarograms of OTC (-----),
OTC Ca(II) 1 5 (------), OTC Ca(II) 1 6 (---), OTC.Ca(II)
1 7 (..... ) and OTC Ca(II) 1 8 (----— ) in 0.1M KCl
observed in the first and second peaks (Ep  ^ and Ep2), however, 
peak three (E^Jis shifted to a more positive potential (15mV) 
and decreased in height to one quarter of its original height 
No change in the fourth peak (Ep4) occurred either As the 
concentration of Ca(II) ions was increased,the first peak (E -j) 
moved to more positive potentials (10m' ) as did peak two (Ep2) 
(15mV), peak three (Ep^) however moved to more positive potentials 
(90mV) and almost became part of the second peak. Peak four 
(Ep4) continues to be reduced at more positive potentials also 
as the concentration of Ca(II) is increased. Overall the formation 
of the Ca(II) complex with oxytetracycline hydrochloride appears 
to induce an ease of reduction of the antibiotic and since 
"addition of an equimolar Ca(II) solution appeared to effect 
peak three (Ep^) this implied that this peak is associated with 
the BCD chromophore and since the peak responsible for reduction 
in the A ring (peak 1) only changes when the concentration of 
Ca(II) is greater than oxytetracycline hydrochloride it was 
concluded that the BCD moeity of oxytetracycline hydrochloride 
has more of an affinity for binding of Ca(II) than does the 
A ring, a similar situation as Cu(II).
On addition of Fe(II) (Fig. 28a and 28b), the potentials
¿A
of reduction of the first wave became more positive by about 
100mV as its concentration was increased up to 4 x 10~^M and 
the half-peak widths decreased from around 100mV to 40mV. This 
indicated that the process responsible for the first wave (E^) 
became much less irreversible in the presence of Fe(II) ions.
The second wave decreased in height as the concentration
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Fig. 28a Differential Pulse Polarograms of Oxytetracycline
hydrochloride (OTC) (---- ),0TC Fe(II) 1 1 (---- ),
OTC Fe(11) 1.2 (---- ), OTC.Fe(II) 1.3 (..... ), and
OTC Fe(II) 1:4 (-------) in 0.1M KCl
i
POTENTIAL vs SCE 
Fig 28b Differential Pulse Polarograms of OTC (-
OTC Fe(II) 1 5 (-— ), OTC.Fe(II) 1.6 (- OTC Fe(II) 
1 7 (..... ) and OTC Fe(II) 1 8 ( - ----- ) m  0 1M KCl
of Fe(II) increased and moved to a more positive peak potential
>
(by 30mV) and remained at this potential. The third peak (Ep3) 
increased in height and its current rose gradually in a manner 
indicative of a catalytic process; peak four (Ep4) is 'hidden' 
behind this catalytic process.
When Ni(II) ions were added to oxytetracycline hydrochloride 
(Fig. 29a and 29b) the relative heights of the first,second 
and third peaks (Epl, Ep2 and Ep3) increased,this does not apply 
to the fourth peak (E 4) which however moved to more positive potentials 
by 20mV (approx). The first peak (Ep1) shifts to a more negative 
potential while the second peak (Ep2) remainedthe same, however 
the current associated with these peaks rose in a manner indicative 
of a catalytic process* Because the fourth peak ( ^ 4) decreased 
in height we can assume that oxytetracycline hydrochloride takes 
part in this reduction. It can not be postulated however to 
what site the Ni(II) is binding to the antibiotic y~In the presence
i.
of Zn(II) ions (Fig. 30a and 30b),peaks one and two were relatively 
uneffected. The third peak (*^3) however gradually decreases 
in height and as it does a new peak appears at -1.37V which 
continues to increase m  height as the concentration of Zn(II) 
ion are increased. The ultraviolet spectral studies of the complex 
give no indication of its site of chelation however since the 
third peak (Ep^) appears to be associated with the 3-diketone 
moeity of the antibiotic, it is resonable to assume that chelation 
of Zn(II) is probably occuring here in preference to the A ring.
The first peak continues to increase m  height as the concentration 
of Zn(II) is increased, no shiftsoccured » therefore no conclusion
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Fig. 29a Differential Pulse Polarograms of Oxytetracycline hydrochloride
(OTC) (-----), OTC Nl (II) 1 1 OTC Ni(II) 1 2 (-•-•)
OTC.Ni(II) 1 3 (••••)_and OTC Ni(II) 1 4 (------) in 0 1 M KCl.
i / \  \
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Fig. 29b Differential Pulse Polarograms of OTC (---- ), OTC Ni(II)
1 5 (----), OTC Ni(II) 1 6 (- - ) ,  OTC Ni(II) 1*7 ( •• )
AND OTC Ni(II) 1 8 (- — ) in 0.1M KCl.
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Fig. 30a Differential Pulse Polarograms of Oxytetracycline hydrochloride
(OTC) ( h  OTC Zn(II) 1:1 (— -), OTC Zn(II) 1.2 (-•-•),
OTC Zn(II) 1 3 ( •••) and OTC Zn(II) 1 4 (-------) in 0.1 M KCl.
I
Fig. 30b Differential Pulse Polarograms of OTC (---- ), OTC Zn (II)
1 5 (----), OTC Zn(II) 1 6 (- -•)> OTC Zn(II) 1-7 ( •• ),
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can be drawn with regard to the A ring of oxytetracycline 
hydrochloride.
In the presence of Mn(II) ion (Fig. 31) the height of all
the differential pulse peaks decreased in size when the Mn(II)
-4
ion concentration was increased to 2 x 10 M. Anew peak also 
appeared at -1.43V which increased in height as the concentration 
of the Mn(II) ion was increased .This wave was obviously due 
to the reduction of Mn(II) to Mn(0). In the presence of an 
equimolar solution of the Mn(II) ion ,no appearent shift occured 
to the first peak (Ep1),however the second peak (Ep2) shifted 
to a more positive potential by 20mV. The remaining waves remain 
uraffected with regard to shifts in potential. If this peak 
is associated with the g-diketone moeity of the antibiotic then 
chelation of the Mn(II) must be occuring here. From the ultraviolet 
spectra of the complexes such a deduction cannot be made since 
no shift in either wavelength (responsible for either of the 
chromophores) occurred.
On addition of the Mg (II) (Fig. 32a) ion, the height of 
the polarographic peaks decreasedin height except the fourth 
wave (Ep4) which increased in height as the concentration of 
the Mg(II) ion was increased. The changes in polarographic 
behaviour again appeared to lie in waves (or peaks) two, three 
and four which are associated with the BCD chromophore of the 
antibiotic.
In the presence of the Co(II) ion (Fig. 32b) the first 
three differential polarographic peaks increased in height as 
the concentration of the Co(II) ion increased However,
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T ö  ----------  — -------'------ “=T5---------'
Fig. 31 Differential Pulse Polarograms of Oxytetracycline hydrochloride
(OTC) (---- ), OTC Mn(11) 1 1 (---), OTC Mn(11) 1 2 (--- ),
OTC Mn(II) 1 3 (....) and OTC Mn(II) 1 4 (- • -) inO.IM KCl.
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the fourth peak (Ep4) firstly decreased in height in the presence 
of equimolar solution of Co(II) ion and proceededto increase 
in height and shift to a more positive potential as the concentration 
of the Co(11) îonwas increased. The first three polarographic 
peaks as well as increasing in height come together to form 
one large broad peak. The addition of the Co(II) ion did not 
change the ultraviolet spectral behaviour of oxytetracycline 
hydrochloride, however its polarographic behaviour is changed 
markedly. Although it cannot be said when the Co(II) is binding 
to the antibiotic it is involved as a catalyst in the evolution 
of hydrogen.
On addition of Al(III) (Fig. 32c), the differential pulse 
polarographic peaks change significantly. The first peak continues 
to move to more positive potentials (by 50mV) as the concentration 
of the Al(III) ion is increased. The remaining peaks move to 
more positive potentials also (up to 80mV). This implies that 
the Al(III) antibiotic complexes become easier to reduce as the
t
concentration of the Al(III) ion is increased. Polarographic 
peaks two and three tend to flatten out and join together as 
the concentration of the Al(III) ion is increased. Peak four 
becomes broader and continues to increase in height as the 
concentration of the Al(III) ion is increased, that is the current 
responsible for the peak continues to rise in a manner indicative 
of a catalytic process. Because all the peak potentials are 
affected dramatically on addition of Al(III) no conclusion 
can be drawn as to the chelating site of Al(III) to 
oxytetracycline hydrochloride.
POTENTIAL vs SCE
Fig. 32a Differential Pulse Polarograms of Oxytetracycline hydrochloride
(OTC) (--- ), OTC Mg(II) 1 1 ( — ), OTC Mg(II) 1 2 (- -•) OTC
Mg(11) 1 3 (...) and OTC:Mg(11) 1.4 (— • -) in 0 1MKC1
' ' POTENTIAL vs SCE 1 ' 1
Fig. 32b Differential Pulse Polarograms of OTC (---- ), OTC'Co(II)
1.1 (----), and OTC.Co(II) 1 2 (------- ) in 0.1M KC1.
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Fig. 32c Differential Pulse Polarograms of OTC (---- ), OTC Al(III)
1 1 (— ), OTC AT(III) 1 2 (-•-•), OTC A1 (III) 1 4 (. ..), 
and OTC Al(III) 1 5 (—  -) in 0 1M KC1
This myriad of changes in the polarographic behaviour of 
oxytetracycline hydrochloride in the presence of metal ions 
of varying valency and position in the periodic table is difficult 
to interpret,because the origin of the differential polarographic 
waves is still a matter of postulation. However, specific metal 
ions tend to bind in a specific manner to the antibiotic. Cu(II),
Ca(II), Zn(II), Mn(II) and Mg(II) tend to interact with the 
antibiotic in a similar fashion i.e. they effect the same waves 
polarographically. Ultraviolet spectral evidence points out 
these metal complexes of axytetracycline hydrochloride to be 
binding to the 3-diketone moeity of the antibiotic,initially 
Fe(II), Ni(II), Co(II) and Al(III) tend to behave differently 
toward the antibiotic. All these complexes have a catalytic 
process associated with them, and ultaviolet spectral evidence 
points out that of the four listed Fe(II) binds to the A ring 
of the antibiotic in preference to p-diketone moeity of it.
In view of the novel polycarbonyl system of this antibiotic 
metals would appear to interact in either of two ways with 
oxytetracycline hydrochloride. From this study of 
the polarography of these complexes it is clear that the BCD chromophore 
of oxytetracycline hydrochloride makes a contribution to the 
overall electroactivity of the antibiotic in aqueous media.
f
C. Cyclic Voltammetric Studies on Oxytetracycline hydrochloride.
Cyclic voltammograms of oxytetracycline hydrochloride 
were obtained (Fig. 33a, 33b, 33c) in the hope that they might 
lead to information regarding the mechanism of reduction of
the antibiotic at the Hg electrode, hence the sites of 
complexation might be more definite. The scan rates were varied. 
The resulting cyclic voltammograms showed inverted peaks 
which are typical of organic analytes and adsorption processes. 
These inverted peaks may be explained on the basis of the 
movement of a Hg electrode surface , due to uneven drop 
polarisation, similar to the approach and
explanation of the first kind of maxima in classical polarography 
Maxima in classical polarography may be of two types, streaming 
and non-streaming maxima When streaming maxima occur on the 
polarographic curve, a vigorous motion of the solution around 
the Hg drop can be observed with a microscope This streaming 
bringsmore depolariser particles to the surface of the electrode 
than can be transported by diffusion Non-streaming maxima 
have some other usually catalytic origin
Another explanation for these inverted peaks concern the 
inhibition of an electrode reaction, as a consequence of its 
coverage by a product of the electrode reaction.
A single cycle at a scan rate of 100mV/sec between 0.8-1.9 V 
of oxytetracycline hydrochloride in 0 1M KC1 pH 5 4 yielded 
five peaks in the forward scan (similar to a polarographic 
reduction in a similar electrolyte). The reverse scan yielded 
3 peaks which were inverted, use of Triton X - 100 as a maximum 
supressor failed to rectify these inverted peaks. When the 
scan rate was reduced to 50mV/sec(all the other parameters 
remaining constant)the forward scan yielded six peaks and the 
reverse scan yielded two peaks which were also inverted Because
Cu
rr
en
t 
1 
C
ur
re
nt
-üb -10 Potenial Vs SCE ' ' -16
Fig 33a Cyclic Voltanimogram of Oxytetracycline hydrochloride (OTC) 
in 0.1M KCl, Scan Rate 100 mV/sec
-09 -10 Potential Vs SCE ' - K  ' -16
Fig. 33b Cyclic Voltammogram of OTC in 0.1M KC1, Scan Rate 
50 mV/sec
-00 10 Potential Vs' SCE ' - U  ' -16
Fig 33c Cyclic Voltammogram of OTC in 0.1M KC1, Scan Rate 
20 mV/sec
of these inverted peaks obtained with oxytetracycline hydrochloride, 
the metal complexes of the antibiotic were not studied as the 
area of inverted peaks is in its infancy, and information that 
might have been obtained from this study could not have been interpreted 
so as to give information which might lead to further understanding 
of the reduction mode of oxytetracycline hydrochloride.
D. Chromatographic Studies on Oxytetracycline hydrochloride 
and its metal complexes
Since metal complexes of oxytetracycline hydrochloride are 
known to exist (spectroscopic and polarographic evidence given 
earlier), an attempt was made to separate these complexes. Because 
of the nature of these complexes reverse phase high performance 
liquid chromotography (rpHPLC) was thought to be a good place 
to begin.
HPLC has already been applied to the separation of metal 
complexes Gaetam et a i  [75] succeeded in separating Co(II),
Ni(II), Cu(II) and Pd(II) complexes of tetradentate &-ketoamines 
Enol e t  a i  [76] have succeeded in separating rhodium and iridium 
triphenylphosphine complexes. Huber e t  a i  [77] have succeeded 
in separating metal 3-diketonates and Gurira et a i  [78] have also 
succeeded in separating 3-diketone-metal chelates. Ultraviolet 
detectors as well as electrochemical detectors have been employed 
to m o m  ter these complexes.
Initially a phenyl column was used in a Z module radial -Cpio- ^ s ■ 
compression system as the stationary phase and different
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combi nations of methanol* Michael is Phosphate buffer and methanol 
phosphoric acid (2 x 10"1Oused as the mobile phase. The retention 
times obtained for oxytetracycline hydrochloride (OTC), 0TC*Cu(II) 
and OTC Fe(III) were similar. This was of no practical use 
and because the metal complexes gave the same retention time 
as the antibiotic itself,it could only be assumed that the 
complexes were breaking down under the conditions on the column 
although high formation constants were reported for such complexes[17]
Because of the amphoteric nature of the oxytetracycline- 
metal complexes and because of the ionic interactions that they 
might undergo with the column, an amino column was used in an 
attempt to separate these complexes. Depending on the pH of
the mobile phase the active group on the column would be involved
in the following equilibrium
+  ^ i +
H + R-NH2 k +  a R-NH3
The interaction that this group might have with the different 
antibiotic metal complexes might thus separate them. This 
amino column can be used in 'reverse' or 'normal' phase separations 
depending on the mobile phase used. Different mobile phases 
were used in this study so that both normal and reverse phase 
separations could be undertaken.-Ethyl acetate chloroform acetone 
were used in various combinations for the normal phase separations 
However, no separation resulted from this work due to the polarity 
of the antibiotic-metal complexes. Other mobile phases such 
as ethyl acetate chloroform in different proportions did not
separate these antibiotic metal complexes and combinations of 
hexane ethyl acetate.methanol proved unsucessful. More polar 
solvent systems such as methanol phosphoric acid and methanol. 
Michael is Phosphate buffer were used to effect reverse phase 
separation Even though different combinations of the above 
solvents were used no separation was observed.
A C18 ^ Bondpak column was used in conjunction with mobile 
phases of water methanol and water acetonitrile (in various 
combinations)in an attempt to effect separation of oxytetracycline 
hydrochloride and its metal complexes Changing the mobile 
phases from 100% to 0% methanol always resulted in oxytetracycline 
hydrochloride eluting before the solvent peak, (oxytetracycline 
hydrochloride eluting at 1.14 minutes the solvent front eluting 
at 2.80 minutes), oxytetracycline Cu(II) 1 1 eluting at 1.67 
minutes and oxytetracycline Cu(II) 1 6 eluting at 3.37 minutes 
and tailing in a mobile phase of methanol water 90 10. Similar 
chromotograms were obtained as the percentage of methanol was 
decreased and the percentage of water increased (Table 7).
In all these cases the antibiotic and the antibiotic metal 
(1 1) complexes eluted before the solvent peak, and only when 
an excess of metal was used in conjunction with the antibiotic 
did a peak elute after the solvent peak, these peaks however 
were tailed.
A C^8 (Nucleosil) column was also used , in conjunction 
with a mobile phase of 50 50 methanol water gave peaks 
for oxytetracycline hydrochloride which eluted
109.
Complex
-
 ^^Mobile Phase Retention Time/minutes 
^ vmethanol water
OTC 100 0 2.48
OTC Cu(II) 1.1 100 0 2.51
OTC Cu(II) 1 6 100 0 2.51
OTC 90 10 1 14
OTC Cu(II) 1 1 90*10 1 67
OTC Cu(II) 1 6 90 10 3 37
OTC 90 10 1 15
OTC Ca(II) 1 1 90 10 1.15
OTC Ca(II) 1 2 90 10 2.68
OTC 90 10 1.10
OTC Fe(III) 1 1 90 10 1.75
OTC Fe(III) 1.6 90 10 3.12
OTC 85 15 1.16
OTC Cu(II) 1.1 85 15 1.19
OTC Cu(II) 1 6 85 15 4.22
OTC 87 13 1.16
OTC.Cu(II) 1 1 87 13 1.22
OTC Cu(II) 1 6 87 13 -
OTC 60 40 1 22
OTC Cu(II) 1 1 60 40 >1.22
OTC Cu(II) 1 6 60 40 -
TABLE 7.
Values Of Retention Times of Oxytetracycline hydrochloride (OTC) 
and its metal complexes using a yBondpak column, Flow Rate 
)1.5 mls/min., ultraviolet detection at 280 nm.
after the solvent peak. These peaks were however badly tailed 
which can only imply interaction of the many functional groups 
of the antibiotic with the sites on the column or the breakdown 
of the antibiotic due to the conditions of the column and/or 
the mobile phase When antibiotic-metal complexes were injected 
onto the column under similar conditions,badly tailed peaks 
also resulted at different retention times to that of the 
antibiotic The tailing observed with the antibiotic metal 
complexes may be explained as discussed earlier for oxytetracycline 
hydrochloride. Even when the percentages of solvents in the 
mobile phase were varied,badly tailed peaks resulted for both 
antibiotic and antibiotic-metal complexes.
The earlier discussion with regard to the characterisation 
of these antibiotic 4netal complexes suggested binding of some 
metal ions to the BCD chromophore Acetyl acetone (ACAC) has 
a structural similarity to the BCD chromophore and ACAC is known 
to form complexes with many metal ions in the +2 and +3 oxidation 
state [79]. Some of these metal chelate appear to be labile 
[80]. Hunter et ai [77] used a ternary mobile phase of 
2,2,4-trimethylpentane, water and ethanol with a. stationary phase 
of ground Kieselguhr and found that addition of the ligand ACAC 
to the mobile phase was necessary if separation of the metal 
chelates was required Gunra et ai [78] succeeded in separating 
similar metal chelates using a C ^  column and a mobile phase 
of methanol water.
Since the ACAC ligand resembles a portion of the antibiotic 
(namely part of the BCD chromophore) where some metals bind, 
the following was attempted to try and achieve separation;
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Fig. 34 Chromatograms of Oxytetracycline hydrochloride and its
metal complexes. Column C^g Bondpak in mobile phase methanol*
-5
water 50 50 + 1 x 10 M'Oxytetracycline Hydrochloride, Ultraviolet 
detection at 280 nm, Flow Rate 1.5 mls/min.
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a mobile phase of methanol water 50 50 in conjunction with a
(bondpak) column. No separation of Oxytetracycline hydrochloride
and its metal complexes occurred, however, until Oxytetracycline
-5
hydrochloride (1 x 10 M) was added to the mobile phase, only then did 
specific peaks occur for the antibiotic and its metal complexes 
(Fig 34). Of the antibioticnnetal complexes analysed,all gave 
very broad peaks if any at a l U  Although Oxytetracycline 
hydrochloride can be distinguised from its metal complexes it 
is not possible to distinguish one type of metal complex from 
the other The resolution between Oxytetracycline hydrochloride 
and its metal complexes is not good however. No peaks were 
obtained for OTC Cu(II), OTC Fe(III) and OTC Ni(II) complexes, 
this can only reflect the lability of the complexes formed.
Although high formation constants have been calculated for these 
complexes [81], this only implies however a thermodynamic stability 
To enable the separation of these complexes using HPLC also 
requires a kinetic stability (inert, non-labile). Cu(II), Fe(III) 
and Ni(11) obviously form labile complexes with oxvtetracycline 
hydrochloride hence it is not possible to separate them using 
HPLC. The broad peaks of the other complexes show them to be 
not as labile as the Cu(II), Fe(III) and Ni(II) complexes 
It would appear that the addition of oxytetracycl m e  
hydrochloride to the mobile phase is imperitive if separation of 
antibiotic-metal complexes is to be achieved. However Gurira 
et ai. [78] has suceeded in separating ACAC complexes of Rh(III), 
Pd(II), Pt(II) and Ir(lII) without addition of ACAC to the 
mobile phase. These metals obviously form very thermodynamically
113.
and kinetically stable complexes with ACAC, These metals would 
probably prove similar with oxytetracycline hydrochloride, but 
since these metals are very rare in an in vivo situation they 
were not studied here. From the chromatograms obtained it would 
appear that some antibiotic metal complexes are more labile 
than others. This lability is however expected since these 
antibiotic metal complexes are ultimately broken down 
in vivo system.
Complex Stoichiometry Retention Time/minute
OTC
OTC:Cu(II) 1 : 1
6.85
OTC:Ni(II) 1 : 1 -
OTC:Cr(III) 1 : 1 6.64
OTC:Fe(III) 1 : 1 10.98
OTC:Co(II) 1 : 1 6.99
OTC:Zn(II) 1 : 1 6.52
OTC:Mg(II) 1 : 1 6.55
OTC:Ca(II) 1 : 1 6.53
0TC:Mn(II) 1 : 1 6.61 -
TABLE 8.
Values of Retention Times of Oxytetracycline hydrochloride and
its metal complexes using a yBondpak C^g stationary phase and
-5
a mobile phase of 50:50 methanol:water + 1 x 10 M Oxytetracycline 
hydrochloride, Flow Rate 1.5 ml/min., ultraviolet detection 
at 280 nm.
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